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ABSTRACT 
EDUARTA HOLL: The role of Plexin-D1 in the adaptive immune system:  
implications for humoral immunity                                                                                              
(Under the direction of Dr Jenny P.-Y Ting) 
                                                               
 
Plexin and semaphorin molecules direct axon localization by generating attractive and 
repulsive forces. Recently, plexin and semaphorin molecules have been shown to control cell 
movement and cell-cell interaction in the immune system. In this study, we characterize the 
expression and function of plexin-D1 in the immune system. We show that plexin-D1 is 
highly expressed in thymocyte, B cell and dendritic cell compartments. Absence of Plexin-
D1 resulted in aberrant thymic development and impaired DP thymocyte migration from the 
cortex to the medulla. However, we found that absence of plexin-D1 did not affect the 
formation of mature T cell compartments and peripheral T cells were capable to respond to 
antigenic challenge. Normal B cell development and maturation was observed in PlxnD1-/- 
mice; however, these mice exhibited defective germinal center (GC) reactions during T-
dependent immune activation. Protective humoral immune responses depend upon the 
generation of memory B cells and long-lived plasma cells formed in the GC reaction. We 
demonstrate that Plexin-D1 is responsible for migration of activated B cells into the GC. We 
correlate these observations with reduced migration of PlxnD1-/- B cells towards the GC 
chemokines, CXCL12, CXCL13 and CCL19. Accordingly, PlxnD1-/- mice exhibited 
defective production of IgG1 and IgG2b, but not IgG3 serum antibody, accompanied by 
reductions in high-affinity antibody, long-lived bone marrow plasmacytes, and recall 
  iv 
humoral memory response. These data show a new role for plexin molecules in the GC 
reaction and generation of immunologic memory.  
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1.1 PLEXINS AND SEMAPHORINS OVERVIEW 
 
Origins: Plexins and semaphorins were discovered over 20 years ago as molecules 
involved in cellular guidance. The nomenclature of semaphorins was derived from the 
analogous properties of these molecules to the system of flags and lights used in maritime 
communication (Kolodkin, Matthes et al. 1993; Luo, Raible et al. 1993; Tessier-Lavigne and 
Goodman 1996). Plexins were identified in Xenopus as molecules expressed in the plexiform 
layers of the neural retina (Takagi, Tsuji et al. 1987; Ohta, Takagi et al. 1992). Two groups 
independently later identified and named them plexin molecules (Ohta, Mizutani et al. 1995; 
Tamagnone, Artigiani et al. 1999).  
Plexins and semaphorins are molecules required to direct axons to their specific 
targets via repulsive or attractive cues (Kolodkin, Matthes et al. 1993; Song, Ming et al. 
1998; Winberg, Noordermeer et al. 1998). While these molecules were identified in the 
nervous system, their utilization in other biological systems has been established. Research 
on plexins and semaphorins has shown that these molecules are important in vasculature 
development, tumor biology, and immune regulation (Granziero, Circosta et al. 2003; Wong, 
Brickey et al. 2003; Gitler, Lu et al. 2004; Walzer, Galibert et al. 2005; O'Connor, Eun et al. 
2008; Yamamoto, Suzuki et al. 2008). The impact of plexins and semaphorins in the immune 
system can elevate our understanding of immune cell-cell interaction, trafficking and 
activation. In this dissertation, I demonstrate and discuss the importance of plexins and 
semaphorins in the immune system, with particular focus in B cell biology.   
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Semaphorins: Semaphorins are large glycoproteins that function in secreted and 
membrane-bound form (Pasterkamp and Kolodkin 2003). All semaphorins contain the “sema 
domain”, a conserved 500-amino acid extracellular domain (1999). The sema domain 
consists of a variant form of the seven-blade β-propeller fold, a highly conserved structure 
widely utilized for protein-protein interactions (Gherardi, Love et al. 2004). Over 20 
semaphorins have been identified and are categorized into groups based on their origin and 
sequence homology: invertebrate, vertebrate and viral semaphorins (1999). The invertebrate 
semaphorin group is further divided into two classes, I and II; whereas, the vertebrate 
semaphorins are divided into groups III-VII (Figure 1.1). Class II, III, and VIII semaphorins 
are secreted whereas the rest are membrane bound (1999). Semaphorins range in size from 
400-1000 a.a. depending on the presence of additional domains, such as immunoglobulin 
(class II, III, IV, and VII) and thrombosponin domains (class V) or GPI linkage sites (Mizui, 
Kumanogoh et al. 2009).  
Semaphorins have two predominant classes of receptors; plexins and neuropilins 
(Takahashi, Fournier et al. 1999; Kruger, Aurandt et al. 2005). Neuropilins are 
transmembrane proteins (~900a.a.) that contain short intracellular domains and thus, lack 
intrinsic signaling capabilities (Takagi, Hirata et al. 1991). Instead, neuropilins form co-
receptor complexes with other cell surface molecules to mediate signal transduction (Kruger, 
Aurandt et al. 2005). The majority of semaphorins signal through plexins alone, however, 
class III semaphorins, with the exception of semaphorin3E, require neuropilin co-receptors to 
properly function (Gu, Yoshida et al. 2005; Chauvet, Cohen et al. 2007). In addition to 
neuropilin and plexin receptors, semaphorins can signal through other receptors, such as 
CD72 and T-cell immunogobulin and mucin domain-containing protein 2 (TIM-2) (Shi, 
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Kumanogoh et al. 2000; Oinuma, Ishikawa et al. 2004). It is clear that semaphorins can 
transmit their signals through a series of receptors. Thus, it is expected that these multiple 
molecular interactions would lead to a variety of signal transductions, perhaps more complex 
than initially thought. 
 
 
FIGURE 1.1 Semaphorins. 
There are eight classes of semaphorins. Classes I and II are found in invertebrates, classes III-VII are 
found in vertebrates and class VIII semaphorins are encoded by viruses. All semaphorins are 
characterized by sema domains which are followed by plexin semaphorin integrin (PSI), 
thrombospondin, and Ig-like domains. They can be either secreted or membrane-bound.  
 
 
Plexins: Plexins are a conserved family of large proteins (~200kDa) that are the 
canonical receptors for semaphorin molecules (Winberg, Noordermeer et al. 1998; 
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Takahashi, Fournier et al. 1999). Like semaphorins, plexins can be soluble or membrane 
bound (Tamagnone, Artigiani et al. 1999). Plexins are divided into four classes, A through D, 
based on their structural homology (Kruger, Aurandt et al. 2005). The invertebrate system 
contains two plexins, termed plexin-A and plexin-B. The vertebrate system contains four 
classes of plexins: class A (Plexin-A1, A2, A3, A4), class B (Plexin-B1, B2, B3), class C 
(C1), and class D (D1) (Figure 1.2). 
 
FIGURE 1.2 Plexins. 
Plexins are divided into four different groups, A-D, based on their origin and structural homology. 
Class B plexins can be secreted whereas the rest of the plexins family members are membrane 
bound.  
 
Plexins are structurally homologous to receptor tyrosine kinases, MET and RON, 
which play important roles in development, tissue regeneration and cancer (Gherardi, Love et 
al. 2004). The extracellular portion of plexin molecules contains a sema domain, followed by 
three plexin-semaphorin-integrin (PSI) domains and three Ig-like, plexins and transcription 
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factors (IPT) domains (Winberg, Noordermeer et al. 1998; Bork, Doerks et al. 1999; 
Antipenko, Himanen et al. 2003). Sema domains are responsible for ligand binding in plexin, 
semaphorin, and the proto-ongogenic MET and RON receptor tyrosine kinases (Antipenko, 
Himanen et al. 2003; Gherardi, Love et al. 2004). In addition to its ligand-binding 
capabilities, the sema domain acts as an autoinhibitory element to restrict activation of plexin 
molecules (Takahashi and Strittmatter 2001). For example, plexinA1 mutants that lack the 
sema domain are constitutively active and nonresponsive to ligand stimulation (Takahashi 
and Strittmatter 2001). Thus, the sema domains can be thought of as a regulatory element of 
plexin and semaphorin proteins that ensures proper activation.  
The PSI domain has also been referred to as a small cystine-rich domain (CDR) or 
MET-related sequence (MRS) and is required for proper protein-protein interactions (Ohta, 
Mizutani et al. 1995). Xenopus studies of plexin-B2 were the first to suggest a role for the 
PSI domains of plexin molecules (Ohta, Mizutani et al. 1995). In these studies, it was 
suggested that ectopically expressed plexin proteins mediate cell adhesion via homophilic 
binding mechanisms of the PSI domains (Ohta, Mizutani et al. 1995). Conclusions on the 
role of PSI domains in plexin interactions were mainly based on previous studies of 
semaphorin3A (Klostermann, Lohrum et al. 1998). Cystine-rich repeats of semaphorin3A are 
responsible for disulfide bond formation in the semaphorin3A homodimer (Klostermann, 
Lohrum et al. 1998). To date, evidence for the role of PSI domains in plexin molecules has 
been sparse.    
IPT domains, also referred to as Ig domains or transcription factor Ig domains (TIG) 
are necessary for ligand binding (Aravind and Koonin 1999). Studies blocking the IPT 
domain of the β2 integrin have suggested that these domains are required for dimerization of 
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the αβ subunits (Huang, Lu et al. 1997; Huang and Springer 1997). Other studies of MET 
proteins, lacking the sema domain, have revealed that the IPT domains alone are sufficient to 
ensure ligand binding (Basilico, Arnesano et al. 2008). Reports of RON proteins lacking an 
IPT domain region have demonstrated that absence of IPT domains causes hyperactive 
kinase activity of this protein and leads to colorectal cancer in humans (Wang, Kurtz et al. 
2000; Zhou, He et al. 2003). Most of the research on plexin IPT domains has been done on 
plexin-A1. Studies of plexin-A1 have shown that absence of IPT domains inhibits association 
of this molecule with a triggering receptor on myeloid cells (TREM) family member and thus 
blocks downstream signaling (Watarai, Sekine et al. 2008).  
The cytoplasmic portion of plexin molecules is essential for signal transduction upon 
ligand binding. Unlike, MET and RON tyrosine kinase receptors, the cytoplasmic tails of 
plexins do not exhibit kinase activity (Maestrini, Tamagnone et al. 1996). The intracellular 
domain of plexins is highly conserved among all classes and it shares homology with the 
intracellular domain of p120 RasGAP (Rohm, Rahim et al. 2000). Plexins contain a GTPase-
binding domain and a segmented GTPase-activating protein (GAP) domain (Kruger, Aurandt 
et al. 2005). Many studies have focused on further elucidating the importance of plexin 
molecules in controlling GTPases (Rohm, Rahim et al. 2000; Oinuma, Ishikawa et al. 2004; 
Eun, O'Connor et al. 2006). These studies are of particular importance given the role of 
plexin molecules in cell movement, cytoskeleton rearrangement and synapse 
formation(Torres-Vazquez, Gitler et al. 2004; Eun, O'Connor et al. 2006). 
In addition to all the components found in plexin molecules, plexin-B1, B2, and B3 
also contain convertase-cleavage sites (Tamagnone, Artigiani et al. 1999). Cleavage and 
binding of these molecules to each other can result in formation of heterodimeric molecules 
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with enhanced activity (Artigiani, Barberis et al. 2003). Moreover, soluble plexin molecules 
can be released in the extracellular environment (Tamagnone, Artigiani et al. 1999), thus, 
eliminating the need for cellular proximity during plexin-semaphorin signaling events.  
 
1.2 PLEXINS AND SEMAPHORINS IN THE IMMUNE SYSTEM 
 
Plexin and semaphorin signaling has gained much interest in field of immunology. 
Immune responses consist of a series of spatiotemporally regulated events that implicate a 
number of different immune cell types. During these events, immune cells interact with each 
other to modulate their course of action. Studies of plexins and semaphorins have revealed 
that several members of these families are involved in a series of immune cell interactions, 
which ultimately influence the outcome of the immune response. Here we present the current 
knowledge of semaphorin and plexin molecules in the immune system.  
 
Semaphorin4D and CD72 in the immune system: Semahorin4D is the first 
semaphorin molecule to be reported in the immune system and is highly expressed by T cells, 
mature DCs, and activated B cells (Delaire, Elhabazi et al. 1998; Kumanogoh, Watanabe et 
al. 2000; Shi, Kumanogoh et al. 2000; Kumanogoh, Suzuki et al. 2002; Granziero, Circosta et 
al. 2003; Kumanogoh, Shikina et al. 2005). Semaphorin4D has two known receptors, plexin-
B1 and CD72, a C-type lectin (Huber, Kolodkin et al. 2003; Zhou, Gunput et al. 2008). The 
functional significance of semaphorin4D has been observed in both human and mouse 
immune systems. Initial studies of human semaphorin4D showed that this molecule promotes 
B-cell aggregation and differentiation (Hall, Boumsell et al. 1996). These studies were later 
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confirmed in the mouse where over-expression of semaphorin4D enhanced CD40- or LPS- 
induced proliferation and Ab production (Shi, Kumanogoh et al. 2000). Semaphorin4D 
regulates B cell immune responses by mitigating CD72 inhibitory signals and thus allowing 
downstream BCR signaling to proceed (Adachi, Flaswinkel et al. 1998; Kumanogoh, 
Watanabe et al. 2000; Kumanogoh, Shikina et al. 2005). The importance of semaphorin4D in 
B cell biology has been further demonstrated in studies utilizing semaphorin4D-deficient 
mice (Shi, Kumanogoh et al. 2000; Kumanogoh, Shikina et al. 2005). In these studies, B cell 
homeostasis is altered in the absence of semaphorin4D. These mice exhibit reduced B-1 B 
cell populations at a young age but increased numbers of marginal zone B cells later in life 
(Shi, Kumanogoh et al. 2000). Additionally, Sema4D-/- mice exhibit impaired T-dependent 
(Td) antibody responses and priming of antigen specific T cells.  
Although T cells are the major semaphorin4D-producing cells in the immune system, 
semaphorin4D-deficient T cells develop normally and respond to antigenic stimuli (Shi, 
Kumanogoh et al. 2000). These studies suggest that semaphorin4D has no direct effect on T 
cells. Other in vitro studies have shown that semaphorin4D recombinant protein is important 
in inducing expression of CD80 and CD86 co-stimulatory molecules on DCs (Kumanogoh, 
Suzuki et al. 2002). Antigen specific Sema4D-/- T cells do not differentiate into effector cells 
when cultured in the presence of DCs. Together these data suggest that semaphorin4D 
expression on T cells is important to promote DC activation and maturation, which in turn 
promotes T cell activation (Kumanogoh, Suzuki et al. 2002). Thus, semaphorin4D exerts its 
function on T cells indirectly via DCs.  
Disease models of autoimmunity in Sema4D-/- mice have revealed that this gene is 
important in controlling T-cell immune responses. Semaphorin4D deficient mice are resistant 
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to myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune 
encephalomyelitis (EAE) (Ishida, Kumanogoh et al. 2003). A role for semaphorin4D in 
humans has been revealed outside the immune system. The absence of functional 
semaphorin4D can lead to death of immature neural cells in the spinal cord, likely, via its 
interaction with plexin-B1 (Giraudon, Vincent et al. 2004). 
  
Semaphorin4A and TIM-2: Semaphorin4A is expressed on DCs and polarized T-
helper type 1 (Th1) cells (Kumanogoh, Marukawa et al. 2002). The only identified receptor 
for semaphorin4A in the immune system is the T cell immunoglobulin and mucin domain-2 
(TIM-2) receptor, a negative regulator of Th2 cells (Kumanogoh, Marukawa et al. 2002; 
Kuchroo, Umetsu et al. 2003; Chakravarti, Sabatos et al. 2005).  
DC-derived semaphorin4A is required for adequate T-cell priming; however, 
semaphorin4A-deficient DCs develop normally and produce cytokines in response to various 
stimuli (Kumanogoh, Shikina et al. 2005). T-cell derived semaphorin4A is required for 
helper T cell differentiation (Th1) via T cell-T cell cognate interactions (Kumanogoh, 
Shikina et al. 2005). Indeed, mice deficient in semaphorin4A exhibit impaired Th1 responses 
to heat-killed Propionibacterium acnes (Kumanogoh, Shikina et al. 2005). However, these 
mice have enhanced responses to a Th2-inducing intestinal nematode, Nippostrongylus 
brasiliensis (Kumanogoh, Shikina et al. 2005). These studies suggest a requirement for 
semaphorinphorin4A in skewing of the T cell response towards a Th1 phenotype. Sema4A-/- 
mice show attenuated development of experimental autoimmune myocarditis, thus, further 
emphasizing the importance of this molecule in immune responses (Makino, Toyofuku et al. 
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2008). Additionally, Sema4A-/- mice on a BALB/c background are more prone to Th2 
responses and develop spontaneous atopic dermatitis (Takamatsu, Okuno et al.).  
 
Semaphorin6D and Plexin-A1: Semaphorin6D is expressed on T, B and NK cells 
(Takegahara, Takamatsu et al. 2006). Plexin-A1 is a well-studied receptor for semaphorin6D 
(Yoshida, Han et al. 2006) and was initially shown to be one of the gene products induced by 
CIITA (Wong, Brickey et al. 2003). Plexin-A1 is highly expressed by mature DCs but is low 
to undetectable in other immune cell types, such as macrophages, B cells and T cells (Wong, 
Brickey et al. 2003). Short hairpin RNA knock down studies demonstrated the functional 
significance of Plexin-A1 in DC biology (Wong, Brickey et al. 2003). DCs that lack 
expression of Plexin-A1 have a reduced capacity to activate T cells both in vitro and in vivo. 
These findings were confirmed in studies of PlxnA1-/- mice (Takegahara, Takamatsu et al. 
2006). In addition, plexin-A1 associates with a molecular complex consisting of i) the 
triggering receptors expressed on myeloid cells-2 (TREM-2) and ii) the immuno-receptors 
tyrosine-based activation motif (ITAM)-bearing adaptor protein (DAP12). DCs deficient in 
TREM-2 or DAP12 behave similarly to plexnA1 deficient DCs (Takegahara, Takamatsu et 
al. 2006), indicating that these adaptor molecules are important mediators of semaphorin6D-
induced plexin-A1 signaling.  
 Plexin molecules can impact the onset of autoimmunity diseases (Kumanogoh, 
Marukawa et al. 2002; Yamamoto, Suzuki et al. 2008). Plexin-A1-deficient mice are resistant 
to MOG-induced EAE (Takegahara, Takamatsu et al. 2006). In part, the generation of MOG-
specific T cells is abrogated in plexin-A1-deficient DCs mitigating the induction of EAE 
upon exposure to MOG antigen. In addition, semaphorin6D has been implicated in the late 
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phase of T-cell responses (O'Connor, Eun et al. 2008) as CD4 T cells initiate expression of 
semaphorin6D by day4 post activation. Blocking semaphorin6D leads to decreased T-cell 
proliferation and inhibition of CD127 (IL-7 receptor) expression on T cells (O'Connor, Eun 
et al. 2008). Taken together these studies suggest that semaphorin6D and plexin-A1 
partnering and signaling are likely to be implicated in regulation of late phases of T-cell 
immune responses and ultimately in generation of immunological memory.  
 
Semaphorin7A, α1β1 integrin and plexin-C1: Semaphorin7A is a GPI-anchored 
protein expressed by CD4+CD8+ double positive thymocytes and activated T cells (Mine, 
Harada et al. 2000). Plexin-C1 and α1β1 integrin are two known receptors for 
semaphorin7A, (Pasterkamp, Peschon et al. 2003; Suzuki, Okuno et al. 2007). Activated T 
cells that express semaphorin7A can stimulate monocytes/macrophages through α1β1 
integrin, inducing proinflammatory cytokine production (Suzuki, Okuno et al. 2007). 
Sema7A-/- mice are resistant to inflammatory diseases such as hapten-induced contact 
hypersensitivity and EAE (Suzuki, Okuno et al. 2007). In addition, semaphorin7A plays a 
critical role in TGF-β1-induced fibrosis, myofibroblast hyperplasia alveolar remodeling, and 
apoptosis (Kang, Lee et al. 2007). These studies indicate that semaphorin7A is important in 
regulating inflammatory immune responses.  
 
Plexin-A4, Semaphorin3A, and Semaphorin6A: Plexin-A4 is expressed by T cells, 
DCs, and macrophages (Yamamoto, Suzuki et al. 2008) and interacts with at least two 
receptors, semaphorin3A and semaphorin6A (Suto, Tsuboi et al. 2007). PlxnA4-/- mice 
exhibit enhanced T-cell priming and exacerbated EAE disease (Yamamoto, Suzuki et al. 
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2008); however, the mechanisms by which plexin-A4 exerts its functions still remain 
unknown.  
 
Plexin-B2: Plexin-B2 is not very well studied in the immune system. To date there 
has only been one report on the role of plexin-B2 in the immune system (Yu, Cook et al. 
2008). Gene expression studies revealed that plexin-B2 is abundantly expressed on germinal 
center (GC) B cells. Plexin-B2 can be used to identify GCs, thus providing a new tool to 
study the GC reaction. The physiological relevance of plexin-B2 however, remains to be 
explored. Plexin-B2 may be required for recruitment and maintenance of activated B cells in 
the GC reaction.  
 
Plexin-D1, Semaphorin3E and Semaphorin4A: Initially, plexin-D1 was identified 
for its key role in vasculature development (Gitler, Lu et al. 2004; Gu, Yoshida et al. 2005). 
PlxnD1-/- mice suffer congenital heart defects due to improper vessel patterning (Gitler, Lu et 
al. 2004; Gu, Yoshida et al. 2005). Studies of plexin-D1 in the immune system have been 
limited. Plexin-D1 is expressed by CD4+CD8+ “double positive” (DP) thymocytes and 
plexin-D1 has been shown to interact with semaphorin3E (Choi, Duke-Cohan et al. 2008) but 
not semaphorin4A (Toyofuku, Yabuki et al. 2007). PlxnD1-/- DP thymocytes are arrested in 
the cortex and seldom travel to the medulla (Choi, Duke-Cohan et al. 2008); however, the 
significance of plexin-D1 deficiency in the peripheral T cell immunity has not been 
determined. Since the elimination of autoreactive T cells occurs in the thymus, plexin-D1 
deficiency may have a role in controlling the development of autoimmunity.  
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As described above, plexins and semaphorins are a new class of immunoregulatory 
molecules with distinct functions in various phases of the immune response. The effects of 
plexins and semaphorins are context- and cell differentiation state-dependent and many have 
complex influences in the immune system as a whole (Table 1.1). Several plexins and 
semaphorins are important in maintaining immunological homeostasis. Lack of these 
molecules can result in attenuated immune responses. Alternatively, several of these 
molecules are required to prevent autoimmune disorders. Despite this body of knowledge on 
the role of plexins and semaphorins in the immune system, more work remains to be done. 
This dissertation focuses on expanding our current knowledge on the importance of plexins 
and semaphorins on adaptive immune responses. We focus primarily on B- and T- cell 
development and activation with particular emphasis on the GC reaction.   
 
Plexin/ 
Semaphorin 
Expression Binding  
Partner 
Activities 
Plexin-A1 DCs, plasmacytoid DCs Semaphorin-6D DC activation 
Plexin-A4 T cells, DCs, Macrophages Class 6 
Semaphorins 
Inhibition of T cell activation 
Plexin-B2 GC B cells Semaphorin-4A Marks GCs 
Plexin-D1 Double positive thymocytes Semaphorin-4A 
and -3E 
Thymocyte trafficking 
Semaphorin-3A T cells Plexin-A family Inhibits T-cell activation and 
monocyte migration  
Semaphorin-4A DCs, activated T cells, Th1 
cells 
Plexin-D1, Plexin-
B2, Tim-2 
T-cell activation and monocyte 
migration 
Semaphorin-4D T cells, activated B cells, DCs CD72 B-cell activation and homeostasis, 
DC activation 
Semaphorin-6D T cells, B cells, NK cells Plexin-A1 DC activation and production of 
type1 interferon, late-phase T cell 
proliferation 
Semaphorin-7A Activated T cells Integrin α1β1 Monocyte/macrophage activation 
 
Table 1.1: Expression of plexin and semaphorin family members in the immune system 
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1.3 B CELL DEVELOPMENT  
 
Immunoglobulin diversity: The bone marrow (BM) contains hematopoietic stem 
cells that give rise to lymphocyte and other blood cells populations (Thomas 1991). B-
lymphocytes arise from committed lymphoid progenitors found in the BM. (Thomas 1991; 
Kondo, Weissman et al. 1997). These cells undergo a series of developmental stages in the 
BM and spleen to give rise to mature B cells (Pillai and Cariappa 2009).  
The B-cell receptor (BCR) is necessary for B-lymphocyte survival and recognition of 
antigens during the course of an immune response (Carrasco and Batista 2006; Srinivasan, 
Sasaki et al. 2009)). The BCR is created by pairing of two different polypeptide chains; the 
immunoglobulin (Ig) heavy chain (HC) and light chain (LC) (Tonegawa 1983). During Ig 
HC rearrangement, gene segments of variable- (V), diversity- (D) and joining- (J) regions are 
assembled in a specific order (D-J, then V-DJ) (Tonegawa 1983). In-frame rearrangement of 
the HC and LC loci occurs when V(D)J rearrangement maintains the correct reading frame 
through the constant (C-) regions of each polypeptide (Schlissel 2004). After successful, in-
frame completion of HC rearrangement, V- and J-gene segments are combined to form the 
LC. Together, the HC and LC form complementarity determining regions (CDRs) that bind 
antigenic structures in their native conformation (Carrasco and Batista 2006). (Figure 1.3) 
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FIGURE 1.3 B-cell development in the bone marrow. 
B cell precursors undergo a series of developmental processes where they rearrange V, D, and J 
gene segments of the HC and LC to give rise to immature B cells.  
 
V(D)J recombination is crucial for the adaptive immune response to allow for a 
diverse array of antigen recognition. Dys-regulation of V(D)J recombination can lead to 
truncated non-productive Ig proteins as well as chromosomal translocations (Baumann, 
Potash et al. 1985). The B-cell repertoire comprises a diverse array of BCR molecules (~1014 
distinct specificities) that promote survival of the host (Dickerson, Market et al. 2003). The 
usage of different C-regions (µ, δ, α, γ, and ε) determines the isotype of the antibody, each 
with unique biological properties (Stavnezer, Guikema et al. 2008). During class switch 
recombination, Cµ is replaced by downstream γ, α, or ε constant regions, yielding switched 
isotypes with the same antigen specificity and affinity (Stavnezer, Guikema et al. 2008). Cδ 
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expression occurs by alternative splicing of the Cµ-Cδ genes (Stavnezer, Guikema et al. 
2008).  
 
Pro- and pre-B-cell Development: Early stages of B-cell development are divided 
based on the rearrangement status of the Ig heavy (Igh) and light chain (Igk or Igl) loci (Chen 
and Alt 1993). During this developmental process, prepro-B cells rearrange and combine the 
D-gene segments to J-gene segments of Igh (Oltz 2001). Pro-B cells continue the 
rearrangement process by adding a V-gene segment to the already rearranged DJ segment 
(Oltz 2001). Pairing of the newly formed HC with surrogate LC leads to pre-BCR formation 
which is necessary for B-cell survival beyond the pro-B cell stage (Martensson, Rolink et al. 
2002). 
Furthermore, pre-B cells are divided into two populations, cycling large pre-B cells 
and non-cycling small pre-B cells (Martensson, Rolink et al. 2002). The large pre-B cell 
stage is characterized by increased proliferation of the cells with successful HC 
rearrangements. This in turn leads to increased numbers of small pre-B cells that can now 
rearrange their LC and further promote diversification of the BCR repertoire. Upon 
successful rearrangement of the LC, IgM antibody (HC+LC) is observed in the cytoplasm of 
small pre-B cells (Wang, Stephan et al. 2002) and in the cytoplasm and surface of immature 
B cells (Wardemann, Yurasov et al. 2003) while the IgD isotype is expressed later during 
development. 
Additionally, early B-cell subsets are identified by flow cytometry using a 
classification system based on differential expression of surface antigens (Hardy, Carmack et 
al. 1991; Osmond, Rolink et al. 1998). In this system, VDJ rearrangement of the Igh loci is 
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determined in cells with the surface phenotype of prepro-B (fraction A-
CD43hiB220loHSAloBP-1negIgMneg), early pro-B (fraction B-CD43hiB220loHSAintBP-
1negIgMneg), late pro-B and large pre-B (fraction C-C`-CD43hiB220loHSAintBP-1hiIgMneg) and 
small pre-B (fraction D-CD43lo/negB220loHSAhiBP-1loIgMneg) cells. This classification system 
is a valuable tool that allows for easy isolation of progenitor B cells for use in subsequent 
experiments. 
 
FIGURE 1.4 B-cell development in the spleen. 
B cells go through T1 and T2 tranzitional stages which then give rise to MZ- and FO- B cells. Both cell 
types are used for different aspects of the humoral immune response.  
 
Immature and transitional B-cell development: Immature and transitional B cell 
compartments are defined by the expression of surface molecules as well as distribution and 
localization in peripheral lymphoid organs (Pillai and Cariappa 2009). Immature and 
transitional B-cell populations are distinguished based on differential expression of fetal 
stem-cell antigen (CD93), IgM, IgD, complement- (CD21) and Fc-receptors (CD23) (Chung, 
Silverman et al. 2003; Casola 2007). Immature B cells are present in both the BM and spleen 
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and express a surface antigen profile (B220intCD21negCD23negCD93hiIgMloIgDneg) that is low 
for BCR and other receptors (CD21 & CD23) whose cross-linking leads to mature B cell 
activation (King and Monroe 2000). BCR cross-linking in immature B cells leads to negative 
selection as these cells undergo apoptosis upon cognate antigen exposure (King and Monroe 
2000). Immature B cells migrate from the BM to the spleen where they differentiate through 
transitional (T) stages into mature B cells capable of responding to antigen (Loder, Mutschler 
et al. 1999; Petro, Gerstein et al. 2002). Transitional type 1 (T1) B cells are present in BM 
and spleen and they give rise to transitional type 2 (T2) B cells which are found only in the 
primary follicles of the spleen (Chung, Sater et al. 2002). T1 B cells 
(B220intCD21negCD23lo/negCD93hiIgMhiIgDneg) do not express IgD BCR, CD21 or CD23 
antigens that are present on T2 B cells (B220intCD21intCD23hiCD93intIgMhiIgDlo/hi). Unlike 
T1 B cells, T2 B cells are characterized as responsive to BCR engagement which results in 
increased proliferation and expression of the prosurvival protein Bcl-x(L).  
 
Mature B-cell compartments: Mature B-cell compartments include three distinct 
populations; mature follicular (FO), marginal zone (MZ), and B1 B cells. FO B cells are 
located in follicles adjacent to T-cell zones; this localization promotes cell-cell interaction 
and migration towards each other when activated to participate in T-dependent immune 
responses (Han, Zheng et al. 1995). FO B cells express high levels of IgD and CD23, but low 
levels of IgM and CD21 (B220+CD23hiCD21loIgMloIgDhi). They circulate and are found in 
the BM, blood, lymph nodes (LN) and mucosal areas where they encounter foreign antigen 
(Pillai and Cariappa 2009). (Figure 1.4) 
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MZ B cells do not circulate in the bloodstream of mice and are long-lived cells that 
do not need constant replenishment from progenitor cells of the BM (Hao and Rajewsky 
2001). They are located between the white pulp (B- and T-cell zones) and the red pulp 
(Dono, Zupo et al. 2003; Lopes-Carvalho and Kearney 2004). MZ B cells express high levels 
of IgM and CD21, but low levels of IgD and CD23 (B220+IgMhiIgDloCD23loCD21hi) (Lopes-
Carvalho and Kearney 2004; Pillai, Cariappa et al. 2005). In addition to B cells, the MZ 
includes metallophilic macrophages and dendritic cells (DC), surrounding the follicular 
mantle (Martin and Kearney 2002). MZ B cells respond to antigenic signals more rapidly 
than FO B cells and are involved in the initial control of pathogen expansion (Snapper, 
Yamada et al. 1993; Oliver, Martin et al. 1997). 
B1 B cells are primarily found in pleural and peritoneal cavities with very low 
frequencies observed in circulation and secondary lymphoid tissues (Hayakawa, Hardy et al. 
1985; Lalor, Stall et al. 1989). The origin of self-renewing B1 B cells remains controversial 
as several reports suggest that these cells arise strictly from fetal liver precursors, whereas 
other reports have suggested that splenic B cells of the B2 phenotype can differentiate into 
B1 B cells (Hardy, Carmack et al. 1991; Bhat, Kantor et al. 1992; Qian, Santiago et al. 2001). 
B1 B cells are distinguished from other B cell populations based on a distinctive pattern of 
cell surface marker expression (B220loIgMhiIgDloCD23loCD21loCD11blo). B1 B cells are 
further subdivided into B1a (CD5+) and B1b (CD5-) subsets(Stall, Adams et al. 1992). B1 B-
cell populations are a major source of circulating natural antibody present in the serum and 
are thought to form a link between innate and adaptive immunity (Nakamura, Burastero et al. 
1988; Nakamura, Burastero et al. 1988; Martin and Kearney 2001). As a front line of 
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immune defense, B1 B cells respond quickly to antigen exposure and promote host survival 
by controlling initial pathogen burden (Ochsenbein, Fehr et al. 1999).  
 
1.4 B-CELL ACTIVATION 
 
T-independent immune responses: B cell immune responses can be divided into 
two categories, those that require helper T cells (Th), termed T-dependent (Td) B-cell immune 
responses and those that can occur in the absence Th cells, termed T-independent (Ti) B-cell 
immune responses (Fagarasan and Honjo 2000). Ti antigens are divided into Ti Type-1 (T1) 
and Ti Type-2 (T2) antigens based on their different mechanisms for B-cell activation. Most 
T1 antigens are polyclonal B cell activators, which include TLR ligands such as LPS, while 
T2 antigens are repeating epitopes of carbohydrate moieties found in pathogenic bacteria 
such as Haemophilius influenzae b, Streptococcus pneumoniae and Neissera meningitides. 
T2 antigens activate B cells by cross-linking of the BCR, resulting in short-lived plasma cells 
(Mond, Lees et al. 1995; Mond, Vos et al. 1995).  
MZ B cells are early responders that differentiate into AFC upon interaction with 
blood-borne bacterial antigens. MZ B cells recognize and respond to antigen challenge 
within hours by proliferating and forming plasmablasts (Lopes-Carvalho and Kearney 2004). 
More recently, it has been demonstrated that MZ B cells engage Td immune responses by 
migrating to the T-B interface of the spleen and act as antigen presenting cells (APCs) 
(Attanavanich and Kearney 2004). It is widely agreed that B-cell memory is the result of Td 
B-cell responses (McHeyzer-Williams and McHeyzer-Williams 2005); however, recent work 
suggests that some Ti type-2 antigen immunizations can form antigen-specific memory B 
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cells (Obukhanych and Nussenzweig 2006). These studies suggest that the Td and Ti immune 
responses are not as distinct as previously described and the importance of MZ B cells 
extends beyond the first few hours of days of the immune response.   
 
T-dependent immune responses: During the course of a Td immune response, 
activated B cells migrate to nearby T-cell zones to interact with activated Th cells. Upon 
encounter with T cells, the activated B cells receive survival, proliferation and differentiation 
signals (Dal Porto, Haberman et al. 1998; Garside, Ingulli et al. 1998; Dal Porto, Haberman 
et al. 2002).  
The initial Td response produces low affinity antigen-specific IgM or IgG from short 
lived plasma cells that reside in the spleen (Jacob, Kelsoe et al. 1991; Liu, Zhang et al. 1991; 
Allen, Okada et al. 2007). The GC reaction, which develops more slowly, gives rise to 
memory B cells and long lived BM plasma cells, the source of rapid and robust serum 
antibody responses characteristic of memory responses (Jacob, Przylepa et al. 1993; Allen, 
Okada et al. 2007). Thus, humoral immune responses are dependent on the quality, 
frequency, and location of antigen-specific, naive B cells. 
 
1.5 THE GERMINAL CENTER REACTION 
 
Overview: The GC reaction is the hallmark of Td humoral immune responses and this 
GC reaction is pivotal in production of high affinity antibody and memory B-cell 
compartments (Kelsoe 1996; Wolniak, Noelle et al. 2006). The GC is comprised of B cells, T 
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cells, follicular dendritic cells (FDCs) and macrophages (Liu, Zhang et al. 1991; MacLennan 
1994; Kelsoe 1996; Camacho, Kosco-Vilbois et al. 1998).   
Previous studies suggest that activated B cells, specific for a foreign antigen, seed the 
GC within a few days after the initiation of the immune response (Jacob, Kassir et al. 1991; 
Liu, Zhang et al. 1991; Wang and Carter 2005). These cells initiate a complex cellular 
program that promotes proliferation, somatic hypermutation (SHM), isotype switching and 
differentiation into AFC and memory cells (McHeyzer-Williams, Driver et al. 2001). 
Activated B cells require additional stimulation (CD40-CD40L) from Th cells in order to 
enter the GC reaction. Disruption of ligation of CD40 by CD40L blocks the formation of 
GCs (Han, Zheng et al. 1995). Indeed, genetic mutations in the CD154 gene (CD40L) lead to 
elevated serum IgM, lack of class-switched antibodies and reductions in affinity maturation 
and B-cell memory (Aruffo, Farrington et al. 1993).  
During the course of the GC response, FDCs capture antigen in the form of immune 
complexes, via CD21, and present this antigen to B cells. Additionally, FDCs secrete 
cytokines that further support B-cell activation and proliferation (Burton, Conrad et al. 1993; 
Wu, Qin et al. 1996; Tew, Wu et al. 1997). Activated FDC networks in the GC express 
vascular adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), 
which bind very late antigen-4 (VLA-4) and lymphocyte function-associated antigen-1 
(LFA-1) respectively, on GC B cells (Koopman, Keehnen et al. 1994; Balogh, Aydar et al. 
2002). These interactions are required to prevent B-cell apoptosis and support B-cell 
differentiation (Koopman, Keehnen et al. 1997). 
The GC is divided into two distinct compartments; the light and dark zone (Close, 
Pringle et al. 1990). The dark zone is characterized by rapidly proliferating B cells 
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(centroblasts), which undergo SHM. The light zone is populated by FDCs that present 
antigen to activated B cells and facilitate clonal selection (Kelsoe 1996). Initial studies have 
suggested rapid movement of GC B cells between the light and dark zones in order to 
facilitate proliferation, mutation and clonal selection (MacLennan 1994; MacLennan 1994; 
MacLennan, Casamayor-Palleja et al. 1997; Allen, Ansel et al. 2004). However, recent 
studies have shown that clonal selection is not restricted to the light zone and can effectively 
occur in the dark zone (Hauser, Junt et al. 2007). These studies also demonstrate that GC B 
cells located in the dark zone are morphologically similar to B cells found in the LZ (Allen, 
Okada et al. 2007; Hauser, Junt et al. 2007). Moreover, these studies indicate that the 
predominant movement of GC B cells occurs as intrazonal circulation; while earlier studies 
suggested DZ to LZ interzonal trafficking. Circulating B cells are frequently found in the 
periphery of the GC where they receive T-cell help (Allen, Okada et al. 2007; Hauser, Junt et 
al. 2007). Together these data suggest that our understanding of the GC reaction is 
incomplete and future studies are needed to elucidate the mechanisms that control the GC 
formation and maintenance.   
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FIGURE 1.5. The GC reaction. 
The GC is divided into LZ and DZ and different chemokines are needed for movement of B cells in 
between and within these zones. 
 
 
Chemokines as key regulators of the GC reaction: The chemokine receptors such 
as CXCR4 and CXCR5 control formation and maintenance of GC (Freedman, Munro et al. 
1990; Forster, Mattis et al. 1996; Arnold, Campbell et al. 2007). CXCL13 is expressed by 
FDCs and directs CXCR5-expressing B cells to the light zone (Allen, Ansel et al. 2004). 
CXCL12 is produced at higher concentrations by splenic stroma in the dark zone and has 
been suggested to control the recruitment of CXCR4-expressing B cells into the dark zone 
(Allen, Ansel et al. 2004). (Figure 1.5) 
Productive GC responses generate high affinity antigen-specific B cells and long-
lived memory B cells, resulting in enhanced protection upon secondary pathogen challenge. 
B cells that express high affinity B cell receptors have undergone somatic hyper mutation 
(SHM) (Jacob, Kassir et al. 1991; Jacob, Kelsoe et al. 1991; Muramatsu, Kinoshita et al. 
2000). SHM requires activation-induced cytidine deaminase (AID); a B cell-specific enzyme 
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that is produced upon B-cell activation  (Muramatsu, Kinoshita et al. 2000; Bransteitter, 
Sneeden et al. 2006). SHM yields mutations in the variable region of the Ig HC and LC. This 
process gives rise to antibodies with varying specificities and affinities for antigen (Manser, 
Wysocki et al. 1987; Jacob, Miller et al. 1992). High affinity B cell clones receive survival 
and differentiation signals from Th cells and FDCs, whereas low affinity or self-reactive 
clones are purged (Berek, Berger et al. 1991; Han, Zheng et al. 1995). The process of 
selecting and expanding high affinity clones is termed affinity maturation (Berek, Berger et 
al. 1991; Han, Zheng et al. 1995; Shokat and Goodnow 1995).  
 
1.6 CLASS SWITCH RECOMBINATION 
 
CSR is an AID-mediated DNA recombination event, which diversifies antibody 
effector functions by replacing the Cµ gene segment (IgM antibody) of Igh with a targeted 
downstream constant region, such as Cα, Cγ, or Cε gene segments (IgA, IgG or IgE 
antibodies) (Stavnezer 2000; Manis, Tian et al. 2002). CSR occurs in the GC and requires 
CD40-CD40L interaction on B and T cells (Renshaw, Fanslow et al. 1994). IgA, -G, and -E 
Ab production is severly reduced in individuals containing a mutated CD40L gene, resulting 
in hyper-IgM syndrome. Recently, CSR has been shown to occur in CD40-/- mice, in T-
independent splenic MZ and intestinal lamina propria immune responses (Renshaw, Fanslow 
et al. 1994; Fagarasan and Honjo 2000). These findings suggest that molecules other than 
CD40 can initiate CSR. Recent work has implicated the tumor necrosis factor (TNF) family 
member, BAFF, in CD40-independent CSR (He, Xu et al. 2007). (Figure 1.6) 
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FIGURE 1.6. Class switch recombination. 
. 
 
1.7 T-CELL DEVELOPMENT 
 
T cells develop in the thymus from blood-borne hematopoietic precursors (Robey and 
Schlissel 2003). CD4 and CD8 double negative (DN) cells represent the earliest committed T 
cell precursor (Singer and Bosselut 2004). These cells can be further divided into four 
different classes (DN1-DN4) based on their expression of CD44 and CD25 (Penit, Lucas et 
al. 1995). DN thymocytes proceed through a series of maturation stages to give rise to double 
positive (DP) cells, which then serve as the precursor pool for CD4 and CD8 T cells (Penit, 
Lucas et al. 1995). Thymic localization is required to ensure proper T cell development and 
education (Benoist and Mathis 1999). DN thymocytes are found in the subcapsular (outer 
cortical) region whereas, DP cells are predominantly found in the inner cortical region where 
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they undergo “positive” selection for appropriate MHC restriction. The thymus contains a 
large number of specialized epithelial cells that can act as antigen presenting cells (Rossi, 
Jenkinson et al. 2006). Thymocytes that survive positive selection migrate to the medulla to 
complete thymic maturation. Autoreactive cells are eliminated in the medulla by negative 
selection (Shortman, Vremec et al. 1998). Additionally, the medulla is populated by antigen-
presenting dendritic cells, which aid in the process of negative selection (Anderson and 
Jenkinson 2001).  
Chemokines are key regulators of thymocyte immigration, emmigration and between 
the thymic compartments (Ansel and Cyster 2001). For example, CXCL12 is a key 
chemokine expressed by stromal cells in the thymic cortex (Suzuki, Sawa et al. 1999) to 
recruit early thymic progenitors that express CXCR4 and ensure cortical localization 
(Plotkin, Prockop et al. 2003). CD25intCD44+ DN thymocytes express CCR7 and migrate to 
the outer thymic cortex in response to CCL19 and CCL21 chemokines (Misslitz, Pabst et al. 
2004). Upon TCR-mediated positive selection, single positive thymocytes elevate expression 
of CCR7 and CCR9 and migrate from the cortex into the medulla (Ueno, Saito et al. 2004), a 
process that allows continued thymocyte differentiation and selection. These studies suggest 
that thymocyte trafficking and T-cell selection are complex processes that are not very well 
understood. Although many of the chemokines studies have proven to be important in cell 
movement, they do not account for all the thymocyte movement patterns that are observed 
during T cell selection. Future work should focus on identifying novel molecules that control 
thymocyte migration and T cell selection.    
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1.8 DC DEVELOPMENT AND FUNCTION 
 
DCs are highly efficient antigen presenting cells (Cella, Sallusto et al. 1997). DCs are 
important in mediating positive and negative selection of T cells in the thymic medulla 
(Hanahan 1998) as well as in eliciting successful immune responses against microbial 
pathogens in peripheral lymphoid organs (Cella, Sallusto et al. 1997). To date, three types of 
DCs have been identified based on their cell surface marker expression: lymphoid DCs 
(CD11c+CD11bLowCD8+, CD205Hi, Mac-1Low), myeloid DCs (CD11c+CD11b+CD8-
CD205-), and plasmacytoid DCs (mPDCA-1+, B200+, Ly6C) (Liu and Nussenzweig ; Liu, 
Waskow et al. 2007; Bogunovic, Ginhoux et al. 2009; Ginhoux, Liu et al. 2009). The 
different subtypes of DCs have specific anatomical locations, thus, giving them distinctive 
functions (Liu, Waskow et al. 2007). For example, lymphoid DCs are found in the thymic 
medulla and the splenic T cell zone, where they induce T cell tolerance and prevent T cell 
responses to self-antigen (Shortman, Vremec et al. 1998). Myeloid DCs are found in the 
marginal zone of the spleen where they readily take up blood-borne foreign antigen (Balazs, 
Martin et al. 2002). They process the antigen and transport it to the rest of the spleen to 
promote T-cell activation or B cell GC responses (Balazs, Martin et al. 2002). pDCs are often 
referred to as IFN-producing cells due to their ability to produce high levels of type I IFN 
upon viral challenge or during the course of autoimmune disease (Martin, Del Hoyo et al. 
2002; Asselin-Paturel, Brizard et al. 2005; Gilliet, Cao et al. 2008).  
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1. 9 CONCLUDING REMARKS 
 
Recent work has enhanced our understanding of the role of plexin and semaphorin 
molecules in cell-cell communication in the immune system. The aim of this dissertation was 
to better understand the role of plexin-D1 in B cell, T cell, and DC development and 
activation during the course of the immune response. In chapter 2, we investigated the role of 
plexin-D1 in humoral immunity. We found that plexin-D1 is important for establishment and 
maintenance of a successful GC reaction. Plexin-D1 contributes to GC formation by 
facilitating recruitment of activated B cells into the GC reaction in response to CXCL12, 
CXCL13 and CCL19 chemokines. Next, we focused on antibody responses in the absence of 
plexin-D1. We found that short-term antibody responses were unaffected in the absence of 
plexin-D1; however, recall humoral immune responses were impaired. The aim of chapter 3 
was to investigate the role of plexin-D1 in T cell development and activation. We found that 
plexin-D1 was important for thymocyte migration from the cortex to the medulla. Plexin-D1 
was dispensable for peripheral T cell and DC maturation and function. This body of work 
adds to our current knowledge of immune plexins and semaphorins. We find plexin-D1 to be 
required for efficient cell movement and localization during humoral immune responses. This 
finding contribute to our current understanding of the GC and could have potential 
implications for future vaccine design aimed at modulation of the GC response and the 
memory B cell compartment.  
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2.1 ABSTRACT 
 
Long-lived humoral immune responses depend upon the generation of memory B cells and 
long-lived plasma cells during the germinal center (GC) reaction. These memory 
compartments, characterized by class-switched IgG and high-affinity antibodies, are the basis 
for successful vaccination. We report that a new member of the plexin family of molecules, 
Plexin-D1, controls the GC reaction and is required for secondary humoral immune 
responses. Plexin-D1 was not required for B cell maturation, marginal-zone precursor 
development, dark and light zone formation, Igλ+ and Igκ+ B cell skewing, B1/B2 
development and the initial extra-follicular response. Plexin-D1 expression was increased 
following B cell activation and PlxnD1-/- mice exhibited defective GC reactions during T-
dependent immune activation. In vivo, PlxnD1-/- B cells accumulated around the GC, but 
failed to efficiently enter the GC. PlxnD1-/- B cells showed a defect in migration towards the 
GC chemokines, CXCL12, CXCL13 and CCL19. Accordingly, PlxnD1-/- mice exhibited 
defective production of IgG1 and IgG2b, but not IgG3 serum antibody, accompanied by 
reductions in high-affinity antibody, long-lived bone marrow plasmacytes, and recall 
humoral memory response. These data show a new role for immune plexins in the GC 
reaction and generation of immunologic memory. 
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2.2 INTRODUCTION 
Plexins were initially identified as molecules involved in axon guidance during 
neuronal development (Kolodkin, Matthes et al. 1993; Winberg, Noordermeer et al. 1998). 
Emerging research on plexins has revealed that many of these family members are 
indispensable in developmental programs of the immune system (Suzuki, Kumanogoh et al. 
2008) and are required for proper immune activation (Granziero, Circosta et al. 2003; Wong, 
Brickey et al. 2003; Walzer, Galibert et al. 2005; O'Connor, Eun et al. 2008; Yamamoto, 
Suzuki et al. 2008). Plexin-D1 was first shown to be important for its role in vasculature 
formation as well as heart development (Gitler, Lu et al. 2004; Gu, Yoshida et al. 2005), but 
recent work demonstrates its role in controlling migration of double positive (DP) 
thymocytes (Choi, Duke-Cohan et al. 2008). Plexins have different ligands by which they 
exert their function. The primary ligands for the plexin family of molecules are the 
semaphorins (Suzuki, Kumanogoh et al. 2008). Plexin-D1 has two known ligands, 
semaphorin-4A and semaphorin-3E (Chauvet, Cohen et al. 2007; Choi, Duke-Cohan et al. 
2008). However, semaphorin-3E, is the only plexin-D1 ligand that has been identified in 
immune tissues (Choi, Duke-Cohan et al. 2008).  
We show that plexin-D1 is most highly expressed by activated B cells and has 
significant effects on their migration, capacity to form germinal centers (GCs) and secondary 
antibody responses.  
Successful activation of B cells during a T-dependent (Td) immune response is 
essential in providing long-term immunity (Jacob, Kassir et al. 1991; Blink, Light et al. 
2005). The Td response results in follicular (FO) B-cell activation and subsequent plasma cell 
development and GC formation (Jacob and Kelsoe 1992). The initial Td response results in 
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low affinity antigen-specific IgM or IgG production by short lived plasma cells that reside in 
the spleen (Jacob, Kelsoe et al. 1991; Liu, Zhang et al. 1991; Allen, Okada et al. 2007). The 
GC reaction, which develops more slowly, gives rise to memory B cells and long lived bone 
marrow plasma cells which provide the rapid and robust serum antibody responses 
characteristic of secondary, memory responses (Jacob, Przylepa et al. 1993; Allen, Okada et 
al. 2007). GCs are the primary sites for affinity maturation, which is characterized by clonal 
expansion and somatic hypermutation (Jacob, Przylepa et al. 1993).  
 Whereas many studies have addressed the GC response and the types of mechanisms 
involved in its initiation and maintenance, we lack a complete understanding of this process. 
Earlier work suggested that the GC is divided into two distinct compartments; the light and 
dark zone (Close, Pringle et al. 1990). The dark zone is characterized by rapidly proliferating 
B cells (centroblasts), which additionally undergo somatic hypermutation. The light zone is 
populated by follicular dendritic cells which present antigen to activated B cells and facilitate 
clonal selection (Kelsoe 1996). This view has recently been revised as new data suggest that 
clonal selection can also occur in the dark zone (Hauser, Junt et al. 2007). GC B cells found 
in the DZ and LZ are not as morphologically different as originally thought (Allen, Okada et 
al. 2007; Hauser, Junt et al. 2007). Additionally, these studies report intrazonal circulation of 
GC B cells and substantial traffic along the GC periphery where B cells are thought to travel 
and receive T cells help (Allen, Okada et al. 2007; Hauser, Junt et al. 2007).  
Previous studies have suggested that activated B cells specific for a foreign antigen 
seed the GC within a few days after the initiation of the immune response (Jacob, Kassir et 
al. 1991; Liu, Zhang et al. 1991; Wang and Carter 2005). B cells are then selected and 
continue on as long-lived plasma cells or memory B cells (Allen, Ansel et al. 2004; Hauser, 
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Junt et al. 2007; Schwickert, Lindquist et al. 2007). Chemokines are key regulators of the GC 
reaction: The chemokine receptors such as CXCR4 and CXCR5 control formation and 
maintenance of GC (Freedman, Munro et al. 1990; Forster, Mattis et al. 1996; Arnold, 
Campbell et al. 2007); CXCL13 and its receptor CXCR5 direct activated B cells to the GC 
light zone and are required for proper positioning of the GC light zone (Allen, Ansel et al. 
2004), and; CXCL12 is thought to be required for the recruitment of CXCR4-expressing GC 
B cells from the light zone into the dark zone (Allen, Ansel et al. 2004). Although the 
identification of key chemokines and their receptors have furthered our understanding of the 
GC reaction, we still lack a complete picture of the molecular mechanisms involved in 
guiding B cells into and out of the GC reaction. Indeed, gene deletion studies focusing on 
CXCR4 and CXCR5-dependent mechanisms have suggested that GC formation is influenced 
by other, yet-to-be identified guidance molecules which traffic activated B cells in and out of 
the GC (Allen, Ansel et al. 2004; Arnold, Campbell et al. 2007; Hauser, Junt et al. 2007; 
Schwickert, Lindquist et al. 2007).  
A gene profiling report found plexinB2 as one of the genes that are expressed by GC 
B cells although the physiological relevance of this finding was not explored (Yu, Cook et al. 
2008). Plexins and their receptors, semaphorins, play significant roles in cell migration and 
positioning in other immune organs and are, therefore, likely candidates to play important 
roles in formation and maintenance of the GC (Suzuki, Kumanogoh et al. 2008). Thus, it is 
important to explore the physiological and functional role of plexins in the GC reaction.  
This report reveals that plexin-D1 is expressed by B lymphocytes and that expression 
is greatly enhanced in activated B cells. Moreover, PlxnD1-/- B cells fail to migrate 
efficiently into GCs in vivo. Additionally, recall immune responses are attenuated in the 
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absence of plexin-D1 leading to defective antibody production. These results indicate a novel 
physiologic role of plexin-D1 in B cell activation.  
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2.3 RESULTS 
PlxnD1 is predominantly expressed in B cells and upregulated by B-cell activation.  
Expression of plexin-D1 in the immune system has not been fully characterized. 
PlxnD1 was recently shown to be expressed by double positive (DP) thymocytes and 
controlled movement within the thymus (Choi, Duke-Cohan et al. 2008), indicating a role for 
PlxnD1 in lymphocyte development and migration. We extended plexin-D1 expression 
studies from immature thymocytes to peripheral T and B cells using RT-PCR (Figure 2.8A) 
and quantitative real-time PCR (Figure 2.8B). PlxnD1 mRNA expression is minimally 
detected in peripheral CD4 and CD8 T cells and in mature T cells that have been cultured 
under Th1 and Th2 skewing conditions. To characterize plexin-D1 expression in B cells, 
splenic (FO) (B220+IgDhiIgMloCD21loCD23hi) and marginal zone (MZ) 
(B220+IgDloIgMhiCD21hiCD23lo) B cells were isolated by flow cytometry. As shown by both 
RT-PCR and real-time PCR, PlxnD1 mRNA was minimally expressed by resting naïve FO B 
cells, but highly expressed by MZ B cells (Figure 2.8A,B). Activation of sorted FO B cells 
with LPS, anti-IgM, and anti-CD40 resulted in dramatically increased (20-30-fold) plexin-D1 
expression, suggesting that this gene might play a role in B-cell immune responses (Figure 
2.8B). Thus in peripheral lymphoid organs, plexin-D1 is constitutively expressed by MZ B 
cells and is upregulated in FO B cells upon activation. These data suggest that plexin-D1 
expression is associated with activated B-cell populations.  
 
PlxnD1-/- B cells exhibit normal development and in vitro activation profiles in mice 
engrafted with PlxnD1-/- fetal liver cells 
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Conventional plxnD1 gene inactivation in mice results in embryonic lethality thereby 
prohibiting any study of a fully developed immune system (Gitler, Lu et al. 2004). To 
determine if the absence of plexin-D1 affects lymphocyte development, lethally-irradiated 
C57BL/6 CD45.1 mice were reconstituted with either WT or PlxnD1-/- fetal liver cells. In 
this system, only the hematopoietic compartment was derived from PlxnD1-/- (CD45.2) 
animals, thus permitting the examination of this gene’s function in blood cells without the 
confounding issue of its expression in other tissues. Donor and recipient hematopoietic cell 
populations were readily distinguished based on the expression of the CD45.1 (host) or 
CD45.2 (donor) allelic markers. Hematopoietic reconstitution of irradiated mice receiving 
either WT or PlxnD1-/- fetal liver was >90% as assessed by flow cytometric analysis of 
splenocytes (Figure 2.1A, i).   
We analyzed B-cell development in the bone marrow of PlxnD1-/- and WT control 
mice by the criteria of Hardy, based on expression of B220, CD43, BP1 and HSA (Figure 
2.1A, ii, iii) (Li, Wasserman et al. 1996). B220+CD43hi cells were separated into three 
populations: BP-1-HSA-, BP-1-HSA, and BP1+HSA+: A (prepro-B cells), B (pro-B cells), and 
C (late pro-B cells). BM of PlxnD1-/- and WT control animals showed no difference in the 
percent of pro-B cells and pre-B cells (Figure 2.1A, iii). These data demonstrate that 
expression of plexin-D1 is not required to generate early progenitor B cell compartments.  
To evaluate B-cell development and maturation, we examined the splenic B-cell 
compartments of PlxnD1-/- and WT control animals using mAbs to B220, IgM, IgD, CD21, 
CD23, and CD93. The immature transitional B cell compartments, defined by IgM, CD23 
and CD93 expression (Wilker, Kohyama et al. 2008), were similar in PlxnD1-/- and WT 
animals, suggesting that B cell development in the spleen is normal (Figure 2.9A). FO B cell 
39 
 
(IgMintIgDhi) frequencies were also comparable between PlxnD1-/- and WT control animals 
(Figure 2.1A, iv). In contrast, when MZ B cells were examined, there was a 2-fold reduction 
in the percentage of these cells in PlxnD1-/- mice compared to WT controls while FO B cell 
percentages remained unchanged, thus, suggesting a potential importance of plexin-D1 in 
MZ function (Figure 2.1B). In addition, we examined the B cell compartment in the 
peritoneal cavity of PlxnD1-/- animals and no differences were found in the percentages and 
numbers of B1 and B2 compartments (Figure 2.9B)  
The proliferation of PlxnD1-/- B cells in response to anti-IgM or LPS stimulation as 
determined by 3H thymidine incorporation (Figure 2.1C) or CFSE dilution (Figure 2.1D) 
was normal in PlxnD1-/- FO and MZ B cells. Histological studies of the spleen revealed 
normal splenic architecture in PlxnD1-/- mice as determined by characteristic white and red 
pulp structure (Figure 2.1E). These data suggest that plexin-D1 is dispensable for B-cell 
proper localization in the spleen.  
 
PlxnD1-/- animals have attenuated germinal center responses. 
The reduction in the percentage of MZ B cells in PlxnD1-/- animals compared to WT 
led us to investigate whether humoral immune responses were affected by the absence of 
plexin-D1. We analyzed basal Ig levels in WT and PlxnD1-/- sera by ELISA. Basal total IgM 
and IgG3 were comparable between WT and PlxnD1-/- animals but IgG1 and IgG2b levels 
were significantly reduced in PlxnD1-/- mice compared to WT mice (Figure 2.1F).  
The defect in TD Ig class switching could be attributed to impaired GC reactions in 
PlxnD1-/- animals. GCs are pivotal sites for facilitating Ig class switching and we analyzed, 
therefore, the formation of GCs in the spleens of PlxnD1-/- and control mice after NP-CGG 
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immunization (Jacob and Kelsoe 1992). Spleens were harvested on day 14 post-
immunization and splenocytes were analyzed by flow cytometry to determine the frequency 
of B220hiGL7hi GC B cells (Arnold, Campbell et al. 2007) present within the total B220+ 
population. While there was no difference at naïve state, PlxnD1-/- animals showed a lower 
percentage of GC B cells when compared to WT post immunization (Figure 2.2A). We 
observed a two-fold reduction in the percentage of GC B cells for PlxnD1-/- mice, at days 7, 
14 and 21, compared to WT (p<0.01) (Figure 2.2B). There was no significant difference in 
the percentages of B220hiGL7+ B cells between WT and PlxnD1-/- mice at day 4, suggesting 
that the kinetics of GC onset were not changed by plexin-D1 (Figure 2.2B). Splenic 
cryosections were labeled with mAbs to TCRb, B220 and GL-7 to determine whether GCs 
form in PlxnD1-/- mice. PlxnD1-/- animals showed a reduction in the size of the GCs as 
determined by histology at Day 14 (Figure 2.2C). B cell contribution to GC formation was 
entirely of donor origin (Figure 2.10A). Additionally, we stained splenic sections with CD21 
to determine the dark and light zone of the GCs in WT and PlxnD1-/- animals (Figure 
2.10B). Our data demonstrate that dark and light zones are present in both WT and PlxnD1-/- 
mice despite the size of the GCs.  
 To expand the analysis of GC frequency in WT and PlxnD1-/- mice, 5-8 non-serial 
sections were prepared from immunized spleen samples (Figure 2.3A). The number of GCs 
were counted and normalized to the number of follicles per section to account for differences 
in area. These results showed that the number of follicles that contained GCs was lower in 
the PlxnD1-/- animals compared to WT controls (Figure 2.3B). To quantify the difference in 
GC size between PlxnD1-/- and WT animals, the area of individual GCs was measured using 
ImageJ software (Figure 2.3C). Whereas WT animals showed a higher distribution of the 
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medium and large GCs, PlxnD1-/- mice contained an elevated frequency of small GCs and a 
reduced frequency of large GCs (Figure 2.3D). A compilation of >200GC/mouse type shows 
that the size of GCs in PlxnD1-/- mice is reduced by approximately 2-fold compared to the 
WT controls (Figure 2.3E). Taken together these data demonstrate that hematopoietic-
derived plexin-D1 controls both the number and size of GCs formed during immunization.  
 The NP-hapten elicits a restricted antibody response to Ighb/l1 mice (Rajewsky 1996). 
To exclude the possibility that the differences we observed in the GC reaction are a result of 
different frequencies of Igλ+ B cells in the absence of plexin-D1, we enumerated Igλ+ B cells 
in PlxnD1-/- mice and found comparable percentages and distributions of Igλ+ B cells to WT 
(Figure 2.11A, B).  We also determined the presence of Igλ+ cells in the GCs of WT and 
PlxnD1-/- mice (Figure 2.11C).  
 
PlxnD1-/- B cells enter GC less efficiently than WT B cells.  
To determine whether the expression of plexin-D1 was required for optimal GC 
formation, irradiated WT mice were reconstituted with fetal liver cells from PlxnD1-/- and 
WT mice (Figure 2.4A). After eight weeks, double chimera mice were immunized with NP-
CGG. Fourteen days after immunization spleens from immunized and naïve mice were 
analyzed by flow cytometry and histology. The reconstitution of irradiated recipients by WT 
and PlxnD1-/- hematopoietic cells were similar, in the fact the latter reconstituted somewhat 
better (Figure 2.4B). We determined the frequency of GC B cells (B220hiGL7hi) in the 
chimeric mice post immunization. Flow cytometry analysis revealed a near three-fold 
decrease in the percentage of GC B cells derived from PlxnD1-/- fetal liver cells compared to 
WT (Figure 2.4B, C). Results obtained from six individual mice are compiled in Figure 
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2.4C. Additionally, we performed immunofluorescence staining on sections obtained from 
the spleens of chimeric mice to determine the presence of WT or PlxnD1-/- B cells in the GC 
(Figure 2.4Di). We observed a lack of CD45.2+ PlxnD1-/- B cells in >70% of the GC 
examined. In a competitive environment, PlxnD1-/- B cells are less efficient than WT cells in 
entering GC. Additionally, we stained splenic sections with CD21 to define the light zone of 
the GC. We observed abundant CD45.1+ WT but only occasional CD45.2+ PlxnD1-/- B cells 
in the light zone of the GCs (Figure 2.4Dii). The majority of PlxnD1-/- B cells accumulated 
around the GCs. These data are consistent with the results obtained earlier with PlxnD1-/- 
mice to indicate that formation of GC is impaired.    
 
B cell expression of plexin-D1 is needed for optimal GC formation. 
To determine whether the defective GC responses observed in PlxnD1-/- mice was 
intrinsic to the B cells compartment, we purified B cells from PlxnD1-/- and WT mice and 
transferred them into B-cell deficient animals (µMT). Ten to fourteen days post B-cell 
transfer, chimeric animals were immunized with NP-CGG and their spleens were analyzed 
14 days later (Figure 2.5A). We performed flow cytometry analysis to determine the 
percentage of GC B cells (B220hiGL7hi) in the chimeric mice post immunization. Our results 
revealed a greater than 3-fold decrease in the percentage of GC B cells in the spleens of 
PlxnD1-/- mice compared to WT mice (Figure 2.5B). These results demonstrate an essential 
function for plexin-D1 expression in B cells for the optimal formation and maintenance of 
GCs. 
 
PlxnD1-/- B cells exhibit reduced migration to CXCL12, CXCL13 or CCL19.  
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 To investigate possible mechanisms behind the reduced size and frequency of GC in 
PlxnD1-/- mice, the response to B-cell chemokines involved in GC recruitment (CXCL12, 
CXCL13 and CCL19) was measured using an in vitro transwell migration assay performed 
with activated B cells. It has been suggested that CCL19, CXCL12 and CXCL13 are 
important in establishing GCs and regulating the migration of B cells within GC. CXCL12 is 
required for recruitment of B cells into the GC dark zone where they undergo rapid 
proliferation. CXCL13 is required for recruitment into the light zone, where the GC B cells 
are thought to be selected and become memory cells (Allen, Ansel et al. 2004).  
In addition to the in vivo experiment described in Figure 2.4 where WT and PlxnD1-/- 
B cells were assessed for their movement into the GC in a competitive assay, we performed 
an analogous experiment where activated WT and PlxnD1-/- B cells were combined in an in 
vitro competitive B cell migration assay towards CXCL12, CXCL13 and CCL19. Migration 
of B cells was quantified by flow cytometry and data are presented as the percent of 
migrating B cells over input. Migration towards these chemokines was uniformly reduced in 
PlxnD1-/- cells compared to WT B cells in the same wells (Figure 2.6A). Another group had 
previously demonstrated that B cells that lack the receptor for CXCL13, CXCR5, are largely 
excluded from the GC and these GCs display abnormal morphology (Allen, Ansel et al. 
2004). Thus, we also assessed the cell surface expression of receptors for CCL19, CXCL12, 
and CXCL13 by flow cytometry. We did not observe significant differences in cell surface 
expression for CCR7, CXCR4, and CXCR5 in naïve or activated B cells (Figure  2.6B), 
indicating that the lack of responsiveness to chemokines was not due to lowered expression 
of the associated chemokine receptors. These observations demonstrate that plexin-D1 
regulates B cell migratory responses to a panel of chemokines important for GC reaction.   
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PlxnD1-/- mice show attenuated secondary humoral immune response.  
Given the impaired GC response of PlxnD1-/- chimeras, we examined the generation 
of humoral immune memory in these mice. The GC reaction is crucial for the efficient 
production of memory B cells and long-lived BM plasma cells, which comprise the cellular 
memory compartments (Jacob, Przylepa et al. 1993; Allen, Okada et al. 2007). To measure 
memory B cell responses, WT and PlxnD1-/- mice were immunized with NP-CGG in alum 
and then boosted with NP-CGG 28 days post primary immunization. Serum samples were 
collected before immunization, 7, 14 and 28 days post primary immunization and 14 days 
after secondary boost. An ELISA to determine both total and high affinity serum Ab was 
performed with all serum samples.  
Naïve PlxnD1-/- or WT mice contained low to undetectable levels of NP reactive IgG1 
Ab, whereas 14 days post immunization NP specific Ab levels in these mice increased 
(~1000-fold) (Figure 2.7A). Primary serum Ab responses of PlxnD1-/- and WT animals did 
not differ (p>0.05) in high or total affinity antibody levels (Figure 2.7A, 7B). Secondary Ab 
responses, however, were significantly reduced (p<0.05) in PlxnD1-/- mice compared to WT 
for both low and high affinity antibody (Figure 2.7A, 7B). These results showed that the 
initial immune response in PlxnD1-/- mice is similar to WT controls while a secondary 
challenge revealed that the recall response is sub-optimal in PlxnD1-/- mice.  
To examine whether antigen-specific class switching AFCs were affected in PlxnD1-/- 
animals, we performed ELISPOT assays to determine the frequencies of NP-specific IgG 
secreting cells in the spleens of immunized mice at 5 and 14 days after primary 
immunization. The number of splenic NP-specific antibody forming cells (AFC) increased 
after immunization compared to naïve controls in both WT and PlxnD1-/- animals. However, 
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the frequency of NP-specific IgG AFC was lower in PlxnD1-/- animals compared to WT 
animals at day 14 but not at day 5 after primary immunization (Figure 2.7C). Interestingly, 
we did not observe a difference in the numbers of NP-specific IgM AFC at day 5 and 14 post 
immunization suggesting that formation of non-class-switched plasma cells is normal in 
PlxnD1-/- animals (Figure 2.12). Taken together these data suggest that initial extrafollicular 
responses in PlxnD1-/- mice are intact. We also compared the levels of NP-specific AFC in 
the BM of PlxnD1-/- or WT control animals following a secondary boost where long-lived, 
memory AFC reside. PlxnD1-/- mice exhibited a reduction of NP-specific IgG AFCs 
following secondary challenge (Figure 2.7D). We correlate a reduction in the frequency of 
NP-specific AFC with reduced levels of IgG1 observed at day 42, which is 14 days after the 
secondary challenge. 
Taken together these data suggest that although initial AFC formation is normal in 
PlxnD1-/- mice, the continued generation of these cells is reduced as compared to WT 
controls.  
We also examined the role of plexin-D1 during a Ti immune response by immunizing 
PlxnD1-/- and WT mice with NP-Ficoll (4-hydroxy-3- nitrophenylacetyl-ficoll) in PBS. There 
were no significant differences in the levels of NP-specific serum IgM between WT and 
PlxnD1-/- mice in response to NP-Ficoll (Figure 2.13). Thus, plexin-D1 expression on B cells 
appears to specifically regulate GCs and the formation of humoral immune memory 
associated with Td responses.  
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2.4 DISCUSSION 
This paper identifies a novel role for plexin-D1 in B-cell biology and represents the 
first demonstration of a plexin molecule that affects GC formation and humoral immune 
memory. In our study, PlxnD1 was expressed at low levels by FO B cells and substantially 
induced by LPS, IgM or CD40 engagement. Despite its relative abundance in activated B 
cells, plexin-D1 was not required for FO B cell development and maturation as all B cell 
subpopulations tested were present in normal frequencies in the bone marrow, spleen, 
peritoneal cavity, and lymph nodes of PlxnD1-/- animals. The enhancement of PlxnD1 
expression by B cells following activation suggested a role for this molecule during the 
course of an immune response. Indeed, immunization with Td antigens resulted in a reduced 
memory IgG1 response in PlxnD1-/- mice compared to the WT mice, accompanied by 
reduced size and numbers of splenic GCs in PlxnD1-/- animals compared to WT. The GC is a 
primary site for class switch recombination, affinity maturation, and plasma cell and memory 
cell development (Jacob, Kassir et al. 1991; Liu, Zhang et al. 1991; Arnold, Campbell et al. 
2007). The reduced percentage of GC B cells was followed by a significant reduction in 
antigen specific AFC formation in the BM following secondary challenge. The size and 
frequency of GCs are important in providing a pool of B cells that develop into AFC 
producing class-switched Ab (Arnold, Campbell et al. 2007). Plexin-D1 is important in 
controlling these events and, thereby, ensures robust humoral responses. Plexin-D1 may be 
important in specifically regulating either the generation or maintenance of memory B cells. 
Both of these events are needed to provide a robust memory immune response and defects in 
either compartment can result in ablated antibody responses (Jacob, Kelsoe et al. 1991; 
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Kelsoe 1996). Alternatively, plexin-D1 may directly regulate GC B cell survival or 
proliferation, affecting the size and number of GCs.   
Early Ti immune responses in PlxnD1-/- animals are not affected, in the context of the 
NP-FICOLL response, despite a reduction in the number of MZ B cells. This suggests 
differential requirements for plexin-D1 during the course of an in vivo immune response 
controlled by different types of B cells. These data resemble the phenotype observed in 
Rap1b-/- animals where the MZ B cell compartment is reduced due to the role of rap1b in 
controlling integrin functions (Chen, Yu et al. 2008). However, Rap1b-/- mice exhibit 
unaltered follicular B cell compartments. MZ B cells can participate in the TD immune 
response by acting as antigen presenting cells and shuttling in and out of the follicles (Martin 
and Kearney 2002). A reduction in MZ B cell numbers can result in altered TD responses. 
However, assessment of early TD responses in PlxnD1-/- suggest that the phenotype observed 
in the absence of plexin-D1 is probably not due to the reduced numbers of MZ B cells. Given 
the emergence of post-GC, antigen-specific and IgG class-switched B cells, we suggest that 
the smaller GC size in the PlxnD1-/- mice may result in a smaller pool of memory B cells 
generated during the primary response, rather than a defect in the ability to produce memory 
B cells.   
Defects in the GC reaction can be the result of abnormal structural organization of 
lymphoid tissues (Matsumoto, Lo et al. 1996).  For example, LTα-/- mice have disturbed 
splenic architecture due to the inability of T and B cells to form distinct T-and B-cell zones 
(De Togni, Goellner et al. 1994). This phenomenon leads to unsuccessful IgG responses in 
these mice following immunization (De Togni, Goellner et al. 1994). Immunohistochemistry 
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analysis of PlxnD1-/- spleens revealed normal splenic architecture, suggesting that the 
separation of B and T cells into distinct compartments is unaffected in these animals.  
Plexins were originally identified in the nervous system as receptors for semaphorins, 
a large class of both secreted and membrane-bound glycoproteins (Kruger, Aurandt et al. 
2005). Plexins are grouped into four different families (A, B, C, and D) based on their 
structural homology (Kruger, Aurandt et al. 2005). Semaphorins are divided into eight 
subclasses; classes 1 and 2 belong to invertebrates, classes 3-7 belong to vertebrates and class 
8 belongs to viruses. Semaphorins can bind to their primary receptors, plexins, alone or in the 
presence of neuropilin receptors. Plexins control cell adhesion via their intracellular domains, 
which contain GTPase-binding structures and are responsible for an array of signaling 
cascades (Sakurai, Gavard et al. ; Oinuma, Ishikawa et al. 2004). Absence of plexins can lead 
to impaired immune responses controlled by various cell types (Granziero, Circosta et al. 
2003; Wong, Brickey et al. 2003; Walzer, Galibert et al. 2005; O'Connor, Eun et al. 2008; 
Yamamoto, Suzuki et al. 2008).  
The importance of plexin-D1 in cell adhesion and migration has been demonstrated in 
both, the vascular and immune system. Absence of plexin-D1 results in aberrant vasculature 
patterning and growth via mechanisms that involve R-Ras and Arf6 (Sakurai, Gavard et al. ; 
Gu, Yoshida et al. 2005). In the immune system, absence of plexin-D1 results in impaired 
activated thymocyte migration towards CXCL12 and CCL23 chemokines (Choi, Duke-
Cohan et al. 2008). We extend these studies to show a role for plexin-D1 in B cell migration 
in peripheral lymphoid organs. In vivo, lack of plexin-D1 results in impaired B cell migration 
into the GC. In vitro, migration of plexin-D1 deficient B cells towards chemokines that are 
implicated in Td immune responses as well as the GC reaction is impaired. CCL19 has been 
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implicated in recruiting B cells to the spleen and further contributing to their ability to travel 
and scan different areas in search for their cognate antigen (Okada, Ngo et al. 2002; Okada, 
Miller et al. 2005). Additionally, CXCL13 is highly expressed in the spleen and is required 
for migration of B cells to the follicles and subsequently to nascent GCs (Forster, Mattis et al. 
1996; Allen, Ansel et al. 2004). CCL19, CXCL12 and CXCL13 are thought to be important 
in setting up GCs and additionally regulating recruitment of B cells to the LZ or DZ (Allen, 
Ansel et al. 2004). Our in vitro migration experiments revealed that activated B cells had a 
reduction in migration abilities towards the tested chemokines, CXCL12, CXCL13 and 
CCL19. This occurred despite the fact that the receptors for these chemokines were 
expressed at normal levels by PlxnD1-/- B cells. These findings suggest that plexin-D1 may 
be important in allowing activated B cells to enter the GC in vivo by facilitating effective 
migration towards GC chemokines. We have identified a novel mechanism regulating B cell 
migration to GC chemokines that is distinct from chemokine receptor expression. The 
mechanisms underlying the ability of plexin-D1 to specifically regulate migration of GC B 
cells to CXCL12 CXCL13 and CCL19 will be examined in future studies.  
The importance of plexins and semaphorins in controlling immune cell development 
and immune responses is recently being appreciated. For example, Plexin-B1 is required for 
proliferation and survival of B cells (Granziero, Circosta et al. 2003). Plexin-A1 expression 
by DCs is needed for proper T-cell activation and proliferation via control of rho activation 
and actin polarization events in DCs (Wong, Brickey et al. 2003; Eun, O'Connor et al. 2006). 
Plexin-A4 is a negative regulator of T cell immune responses and its absence leads to 
development of autoimmunity in mice lacking plexin-A4 (Yamamoto, Suzuki et al. 2008). 
Most recently, expression of plexin-B2 in B cells was used to identify GCs (Yu, Cook et al. 
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2008). In this study, we have identified plexin-D1 as a novel regulator of humoral immune 
memory. Some of the defects observed over the course of a Td immune responses could be 
attributed to the inability of activated PlxnD1-/- B cells to migrate to the GC. These studies 
show that a single member of the plexin family can exert various functions on different cell 
types (T and B) depending on the stage of cell development or the state of immune 
activation. Further studies involving PlxnD1-/- T cells and B cells are needed to define the 
role of this molecule in different types of immune responses. Plexin-D1 is the first plexin 
shown to be directly involved in the control of GCs and consequently control of humoral 
immune memory. This finding has implications in vaccine design in terms of targeting the 
GC and promoting long-term immunity.  
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2.5 MATERIALS AND METHODS 
 
Mice  
C57BL/6 and congenic C57BL/6 CD45.1 mice were obtained from the National 
Cancer Institute (Boston, MA). PlxnD1+/- mice were a generous gift from Dr. Thomas 
Jessell’s laboratory and have been described in (Gu, Yoshida et al. 2005). µMT mice (Igh-
6tm1Cgn) were obtained from The Jackson Laboratory (Bar Harbor, ME). Mice were housed in 
a pathogen-free barrier facility at University of North Carolina. These studies were approved 
by the University of North Carolina Animal Care and Use Committee. 
For fetal liver chimeras PlxnD1+/- mice were crossed for over 10 generations with 
C57BL/6 mice and intercrossed to obtain PlxnD1-/- and PlxnD1+/+ embryos. PlxnD1+/+ and 
PlxnD1-/- fetal livers were prepared from E14 embryos post PCR genotyping as previously 
described (Gu, Yoshida et al. 2005). Five million fetal liver cells were then injected (iv) into 
lethally irradiated C57BL/6 CD45.1 mice. Mice were analyzed 6-10 weeks post 
reconstitution. For mixed chimera experiments fetal liver cells were obtained from PlxnD1-/- 
embryos (CD45.2) and PlxnD1+/+ embryos (CD45.1), mixed (1:1 ratio) and injected into 
lethally irradiated C57BL/6 CD45.1 recipient mice. Mice were allowed to reconstitute for 6-8 
weeks before use.  
 For µMT experiments, B cells were isolated form PlxnD1-/- and PlxnD1+/+ mice and 
2 x 107 to 4 x 107 mice were injected intravenously into µMT animals. Mice were allowed to 
reconstitute for 10 days and were then used for experiments.  
 
Immunizations. 
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NP-CGG immunization: Fetal liver chimeric mice were immunized (ip) with NP18-
CGG (4-hydroxy-3- nitrophenylacetyl18-chicken gamma globulin) (10mg) precipitated in 
alum and suspended in 200ml PBS. Mice were bled before, 4, 7, 14 and 28 days after 
immunization to determine antigen-specific serum Ab levels. Spleens were harvested 4, 7, 14 
and 21 days post-immunization and analyzed via FACS and immunofluorescent labeling of 
tissue sections. Remaining animals were boosted with NP18-CGG (10 mg) at 28 days post 
primary immunization. Serum was then collected 14 days post boost. NP-Ficoll 
immunization: Fetal liver chimeric animals were immunized (ip) with NP-Ficoll (25mg) 
suspended in 200ml PBS. Mice were bled before, 3 and 5 days after immunization to 
determine antigen-specific serum Ab levels.  
 
ELISA  
ELISA plates (BD Falcon) were coated with 2µg/ml (50µl/well) of capture reagent 
goat anti-mouse Ig(H+L), NIP2-BSA or NIP25-BSA in 0.1M Carbonate Buffer (pH9.5) 
overnight at 4°C. Detection antibodies included HRP-conjugated goat anti-mouse IgM and 
goat anti-mouse IgG1, 2b, and 3 from Southern Biotechnology Associates (Birmingham, AL). 
Each serum sample was diluted 1:333 and was followed by 5-10 serial 3-fold dilutions and 
assayed in duplicate. Purified mouse IgM and IgG mAb were used to generate standard 
curves beginning at 1µg/ml and diluted to 6 ng/ml.  
 
In vitro B-cell migration  
B cells were sorted form the spleens of WT and PlxnD1-/- animals and suspended in 
RPMI 1640 with 0.1% fatty acid free BSA. Cell were resuspended at a density of 107 cells 
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per ml and incubated at 37°C for 30 minutes prior to transwell migration assay. Media 
(100ml) was added to the upper chamber of a 24-well migration plates with a pore size of 
5mm (Corning Costar). Top chambers were inserted into wells containing 600µl of media 
with CCL19 (500ng/ml), CXCL13 (500ng/ml) or CXCL12 (150ng/ml). Plates were 
incubated for 2hrs at 37°C. All cells were counted by flow cytometry as previously described 
(Allen, Ansel et al. 2004).  
 
ELISPOT  
Antigen-specific AFC: ELISPOT plates (Millipore) were coated with 2µg/ml (50 
µl/well) of NP25-BSA or goat anti-mouse Ig(H+L) in 0.1M Carbonate Buffer (pH9.5) overnight 
at 4°C. One million splenocytes (5d and 14d post primary immunization) and 1 million BM 
cells (14d post boost) obtained from immunized animals were serially diluted and plated in 
triplicate. Cells were incubated at 37°C in a humidified CO2 incubator for 4h. Plates were 
washed and re-blocked for 24hrs using blocking buffer (1xPBS (pH7.4), 0.1% Tween-20 and 
0.5% BSA). Membranes were probed with AP-conjugated IgG (Southern Biotechnology 
Associates, Birmingham, AL) and spots were developed with SIGMA FAST BCIP/NBT 
(Sigma).  
 
Cell culture 
 Proliferation assays: B cells were sorted by FACS or using a B-cell negative 
selection kit (Stemcell Technologies). 2x105 purified B cells were cultured in RPMI media 
(Gibco) containing 10% FBS, 10-4M 2-ME and penicillin/streptomycin (P/S) antibiotics in 96 
well plates. Cells were cultured in the presence of 5 µg/ml LPS (SIGMA) or 5µg/ml anti-µ 
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(Jackson ImmunoResearch) for 48 hours. One mCi of 3H thymidine was added to the cultures 
for the last 8 hours to assess proliferation. FACS sorted FO (B220+CD21loCD23hi) B cells 
were labeled with 5mM CFSE (Sigma) and cultured in the presence of 5µg/ml IgM or 
5µg/ml LPS. Proliferation was assessed by flow cytometry after 72 hours. B cell activation: 
FO and MZ B cells were sorted from the spleens of C57BL/6 animals and cultured in the 
presence of 5 µg/ml LPS (SIGMA), 1mg/ml anti-m (Jackson ImmunoResearch), or 1µg/ml 
anti-CD40 (eBiosciences) for 72 hours. RNA and cDNA for RT-PCR and quantitative real-
time PCR were prepared as described above. 
 
Antibodies and FACS  
Monoclonal Abs included: B220 (RA3-6B2), CD23 (B3B4), BP-1 (6C3), CD24 
(M1/69), CD43 (S7), GL-7 (GL-7) and APC-Alexa750-conjugated streptavidin from BD 
Pharmingen (San Diego, CA); IgM (eB121-15F9), IgD (11-26), CD21 (eBio8D9), CD93 
(AA4.1), CD5(Ly-1), CD45.2 (104), CD4 (L3T4), CD8 (Ly-2), and TCRβ (H57-597) from 
eBioscience (San Diego, CA); Igκ, Igλ from Southern Biotech (Birmingham, AL); CD38 
(90) and IgG1 (RMG1-1) from Biolegend (San Diego, CA). Secondary antibodies included 
anti-FITC-Alexa488, Alexa350-conjugated streptavidin and Alexa405-conjugated 
streptavidin from Invitrogen (Raleigh, NC). Single cell suspensions of different tissues were 
counted and 106 cells were suspended in FACS buffer (1xPBS plus 2% FBS) and stained 
with various antibody combinations. All flow cytometry was performed on a FACSCalibur 
or LSRII cytometer (BD Biosciences) and analyzed with FlowJo software (Tree Star). Cell 
sorting was performed on a MoFlo cytometer (Beckman-Coulter).  
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Histology  
Spleens from naïve and immunized mice were embedded in OCT compound, snap 
frozen, and stored at -80°C. 5 µm sections were prepared and fixed with 1:1 
Acetone:Methanol for 10 min at -20°C and labeled with various combinations of B220-
biotin, B220-FITC (green), B220-PE (red), TCRβ-PE (red), GL-7-FITC (green), CD21-
biotin, Igλ-FITC (green), Igκ-biotin, CD45.1-FITC, -PE, or –biotin, and CD45.2-FITC, -PE, 
-Biotin mAb. FITC signal was amplified using anti-FITC-Alexa488 mAb. Streptavidin-
AlexaFluor350 or Streptavidin-AlexaFluor405 was used to amplify -biotin signal (blue). 
Additionally, sections from various spleens were H&E stained. Images were acquired using a 
Zeiss Axiovert 200M or Zeiss LSM 710 confocal immunofluorescent microscope. 
 
Statistical analysis 
Statistical significance was determined with two-tailed Student’s t test. All p values 
less than 0.05 were considered significant.  
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Figure 2.1. Normal in vitro function exhibited by PlxnD1-/- B cells 
 (A) Reconstitution of irradiated recipients with WT and PlxnD1-/- fetal liver cells. BM and 
spleen cells were harvested from WT and PlxnD1-/- mice and analyzed by flow cytometry.  
Monoclonal Ab to CD45.2 was used to label splenocytes and to determine the percent of 
reconstitution. WT and PlxnD1-/- fetal liver cells reconstituted equally well (i). Monoclonal 
Abs to B220 and CD43 (ii), and HSA and BP1 (iii) were used to determine the percentages 
of B cell progenitors in the bone marrow using Hardy’s fractionation (ii, iii). Monoclonal 
Abs to B220, IgM, and IgD were used to determine the percentage of mature FO B cell 
population in the spleen (iv). Plots are pre-gated on live CD45.2+B220+ lymphocytes. Data 
are representative of 10 mice for each genotype. Mean percentage ± SEM is indicated for 
each cell type. (B) Monoclonal Abs to CD45.2, B220, CD21, and CD23 were used to 
determine the percentage of MZ B cell populations in the spleen, WT (solid bar) and PlxnD1-
/- (open bar). Plots were pregated on B220+ splenocytes. Graph represents data pooled from 9 
mice in 3 different experiments. **p<0.01 (C) Proliferation of B cells from mice 
reconstituted with PlxnD1-/- and WT fetal liver cells as assessed by 3H thymidine uptake. WT 
(solid bar) or PlxnD1-/- (open bar) FO B cells were cultured in the presence of 5µg/ml anti-
IgM or 5µg/ml LPS for 48 hours. Cells were pulsed with 3H thymidine for the last 8 hours in 
culture to determine cell proliferation and data are presented as counts per minute (c.p.m). 
n=9 mice per group. Data are representative of 3 independent experiments. (D) Proliferation 
of PlxnD1-/- and WT B cells as assessed by CFSE dilution. FO and MZ B cells were labeled 
with CFSE and cultured in the presence of 5µg/ml IgM or 5mg/ml of LPS for 72 hours. 
Proliferation was assessed by flowcytometry and data are representative of 3 independent 
experiments. n=9 mice per group. (E) Splenic structure of mice reconstituted with PlxnD1-/- 
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and WT fetal liver cells. H+E staining of 5µm spleen cryosections was performed. Five 
spleens were analyzed for each genotype. (F) Serum Ig levels in mice reconstituted with 
PlxnD1-/- and WT fetal liver cells. Serum was harvested from naïve mice 8 weeks post fetal 
liver cell transplant. Basal levels of Ab were determined by ELISA using goat anti-mouse 
Ig(H+L) as capture reagent. Ab was detected using HRP labeled goat anti mouse IgM, IgG1, 
IgG2b or IgG3. Data were pooled from 3 independent experiments. n=9-14 mice per group. 
59 
 
 
Day 0 Day 14
G
C
 B
 c
e
ll
s
 (
%
 o
f 
B
2
2
0
+
) WT
PlxnD1-/-
100µm
D0
D14
WT PlxnD1-/-
G
L
7
B220
D0
D14
B220 TCR! GL7
0.64 0.56
2.2 1.07  
A
B
C
**
Figure 2
B
T
B
B
B
B
T
T
T
B
GC
GC
WT PlxnD1-/-
102100 101 103 104 102100 101 103 104
102100 101 103 104 102100 101 103 104
102
100
101
103
104
102
100
101
103
104
102
100
101
103
104
102
100
101
103
104
**
**
Day 4 Day 21
0.0
0.5
1.0
1.5
2.0
2.5
Day 7
60 
 
Figure 2.2. Impaired germinal center response in PlxnD1-/- mice.  
(A) Reduced frequency of GC B cells in mice reconstituted with PlxnD1-/- cells relative to 
those with WT cells as measure by flow cytometry. Mice were immunized (ip) with 10 mg 
NP18-CGG in alum and spleens were harvested at day 14 post immunization. Cells were 
labeled with mAbs to CD45.2, B220, IgM, IgD, TCRβ and GL-7. The percent of B220hiGL-
7hi B cells of total B220hi cells was determined by flow cytometry. (B) Reduced frequency of 
GC B cells in PlxnD1-/- (open circle) mice relative to WT (closed circle) mice. Quantification 
of GC B cells as measured by flow cytometry. The graph is representative of 3 independent 
experiments. Each point represents data from one mouse. Small horizontal bars indicate 
mean values. **p<0.001. (C) Reduction of GC size in mice reconstituted with PlxnD1-/- cells 
relative to those with WT cells as measured by histology. Five mm sections of spleens from 
WT and PlxnD1-/- mice at day 14 post immunization were labeled with B220-AF350 (blue), 
TCRβ-PE (red) and GL-7-FITC (green) antibodies. FITC signal was amplified using anti-
FITC-AF488 Ab.  Images were acquired using a Zeiss Axiovert 200M confocal 
immunofluorescent microscope. Day 0 samples are shown as control. n=10 mice per group. 
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Figure 2.3. Decreased number and size of GCs in PlxnD1-/- mice.  
(A) Schematic of experimental design. (B) Reduced GC number in PlxnD1-/- (open circle) 
mice than WT (solid circle). Number of GCs was counted using 5-8 different 5µm sections 
for each mouse spleen divided by the total number of B cell follicles. Each point represents 
data from one mouse. Data were pooled from 3 independent experiments. Small horizontal 
bars indicate mean values. **p<0.001. (C) Reduced size in PlxnD1-/- mice than WT. Images 
were acquired using a Zeiss Axiovert 200M confocal immunofluorescent microscope. Size of 
individual GCs was determined using ImageJ. (D) Reduced percentage of larger GC in mice 
reconstituted with PlxnD1-/- cells (open bar) compared to WT (solid bar). GCs were divided 
into three groups: small (<12,000µm2), medium (12,000-25,000 µm2) and large 
(>25,000µm2). The number of GCs in each group was divided by the total number of GCs 
and presented as a percentage. More than 200 GCs were analyzed for each group. (E) 
Reduced GC area in PlxnD1-/- mice. Area of individual GCs was determined 14 days post 
primary NP-CGG immunization using ImageJ. Data are pooled from three independent 
experiments. n=13. ***p<0.0001.   
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Figure 2.4. PlxnD1-/- B cells enter GC less efficiently than WT B cells.  
(A) Schematic of experimental design. (B) Similar hematopoietic reconstitution but reduced 
frequency of PlxnD1-/- derived GC B cells relative to those with WT cells as measured by 
flow cytometry. Mice were immunized (ip) with NP-CGG in alum and spleens were 
harvested at day 14 post immunization. Cells were labeled with mAb to CD45.1, CD45.2, 
B220, IgM, IgD, TCRβ and GL-7. The percent of PlxnD1-/- CD45.2+B220hiGL-7hi B cells of 
total B220hi cells was determined by flow cytometry and was reduced relative to the 
percentage of WT CD45.1+B220hiGL-7hi controls. n=6 mice per group. Mean±SEM are 
presented for each genotype. Data were obtained in two separate experiments. (C) Reduced 
frequency of GC B cells in PlxnD1-/- (open bars) B cells relative to WT (closed bars) B cells. 
Quantification of GC B cells as measured by flow cytometry. The graph is representative of 2 
independent experiments. Each point represents data from one mouse. **p<0.001. (D) 
Splenic sections from chimeric mice were stained with various combinations of CD45.1, 
CD45.2, GL7 and B220 antibodies to determine the presence of WT and PlxnD1-/- B cells in 
the GCs (i). Splenic sections from WT/PlxnD1-/- chimeric mice were stained with various 
combinations of CD45.1, CD45.2, IgD, and CD21 antibodies to determine the presence of 
WT and PlxnD1-/- B cells in the GC light and dark zones (ii). Images were acquired using a 
Zeiss LSM 710 confocal immunofluorescent microscope. n=6 mice per group. 
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Figure 2.5. Plexin-D1 deficiency in B cells alone results in reduced percentages of GC B 
cells.  
(A) Schematic of experimental design. (B) Reduced frequency of GC B cells in B-cell 
deficient mice (µΜΤ) reconstituted with PlxnD1-/- B cells relative to those with WT cells as 
measure by flow cytometry. Mice were immunized (ip) with NP18-CGG in alum and spleens 
were harvested at day 14 post immunization. Cells were labeled with mAb to CD45.2, B220, 
IgM, IgD, TCRβ and GL-7. The percent of B220hiGL-7hi B cells of total B220hi cells was 
determined by flow cytometry and was reduced in µMT animals reconstituted with PlxnD1-/- 
(open circle) B cells relative to WT (solid cirle) controls. Each circle represents an individual 
mouse. Data are representative of 2 independent experiments. Small horizontal bars indicate 
mean values.  
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Figure 2.6. Impaired in vitro migration of activated PlxnD1-/- B cells but normal surface 
chemokine receptor expression.  
(A) Purified WT (open bar) and PlxnD1-/- (solid bar) B cells were placed in the same well 
and subjected to competitive in vitro migration assays in the presence of medium alone, 
CXCL12, CXCL13 and CCL19 (Figure. 6A). WT and PlxnD1-/- B cells were differentiated 
by CD45.1 and CD45.2 expression. Migrated cells were quantified by flow cytometry and 
are presented as percent of total input cells. Purified WT and PlxnD1-/- were activated in the 
presence of anti-IgM and anti-CD40 for 24 hours and then subjected to in vitro migration 
assays as described. Data are pooled from three independent experiments. n=6-7 mice per 
group. (B) Spleen cells were harvested from PlxnD1-/- (black line) and WT (gray line) mice 
and analyzed by flow cytometry. Monoclonal Abs to CD45.1, CD45.2 and B220 were used 
to identify the fetal liver donor B cells and then mAbs to CCR7, CXCR4, or CXCR5 were 
used to stain these cells (top). B cells were isolated from PlxnD1-/- and WT spleens and 
activated with anti-CD40 and anti-IgM for 24 hours (bottom). n=5 mice per group.   
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Figure 2.7. Impaired secondary Td immune response in PlxnD1-/- mice.  
(A, B) Serum Ig levels after primary and secondary immunization in WT (solid line) and 
PlxnD1-/- (dotted line) mice. Mice were immunized (ip) with NP18-CGG in alum and boosted 
at day 28 post primary immunization. Serum was harvested at various time points. Ab levels 
were measured by ELISA. Data were pooled from three independent experiments. **p<0.01 
and n=11 mice per group. (C) Antigen specific splenic AFC formation in mice reconstituted 
with WT (solid bar) and PlxnD1-/- (open bar) fetal liver cells. Spleens were harvested at day 5 
and 14 post-immunization. NP-specific IgG AFCs were enumerated by ELISPOT on wells 
coated with NP25-BSA. (D) Antigen specific bone marrow AFC formation in mice 
reconstituted with PlxnD1-/- and WT fetal liver cells. Bone marrow was harvested at day 14 
post-secondary immunization. NP specific IgG AFCs were enumerated as above. Data were 
pooled from 3 independent experiments. Representative pictures of ELISPOT wells are 
shown below each graph. Mean±SEM. **p<0.01 and n=10 mice per group.  
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Figure 2.8. Expression of plexin-D1 by lymphocytes.  
(A) Expression of PlxnD1 in the spleen, resting CD4 and CD8 T cells, MZ and FO B cells, 
Th1 and Th2 cells, assessed by RT-PCR. Data are representative of three independent 
experiments. (B) Expression of PlxnD1 in sorted resting T cells, FO and MZ B cells, and 
activated B cells as assessed by real-time PCR. All values were normalized to HPRT. B cells 
were cultured in the presence of LPS (5 µg/ml), anti-µ (1µg/ml), or anti-CD40 (1µg/ml) for 
72 hours. All splenocytes used for RT-PCR along with real-time PCR were labeled with 
mAb to CD4, CD8, CD62L, B220, IgM, IgD, CD23 and CD21 and purified by FACS sorting 
into CD4+CD62LHi (CD4 T cells), CD8+CD62LHi (CD8 T cells), 
B220+IgDHiIgMLoCD21LoCD23Hi (FO B cells), B220+IgDLoIgMHiCD21HiCD23Lo (MZ B 
cells). Data are representative of three independent experiments. Mean±SEM. n=8 mice.  
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Figure 2.9. Normal B cell development in PlxnD1-/- mice.  
(A) Splenocytes were harvested from WT and PlxnD1-/- mice and analyzed by flow 
cytometry. Monoclonal Abs to B220, CD93, IgM and CD23 were used to determine the 
percentages of immature (B220+CD93+) and mature (B220+CD93-) splenic B cells among 
total splenocytes. B220+CD93+ cells were then divided into transitional B cell compartments 
T1, T2, and T3 based on their IgM and CD23 expression. Plots are pre-gated on live CD45.2+ 
splenocytes. Data are representative of 4-5 mice for each genotype. Mean percentage ± SEM 
is indicated for each cell type. Data are representative of two independent experiments. Total 
numbers of cells are expressed in the corresponding graphs. WT (solid bar) and PlxnD1-/- 
(open bar). (B) Peritoneal cavity lavage cells were harvested from WT and PlxnD1-/- mice 
and analyzed by flow cytometry. Monoclonal Abs to CD45.2, IgD, IgM were used to 
determine the percentage of B1 and B2 B cell populations in the peritoneal cavity. Further 
analysis of IgDLoIgMHi populations by CD5 was used to separate these cells into B1a 
(B220LoCD5+) and B1b (B220LoCD5-) B cell compartments. Data are representative of 4-5 
mice for each genotype. Mean percentage ± SEM is indicated for each cell type. Data are 
representative of two independent experiments. Total numbers of cells are expressed in the 
corresponding graphs. WT (solid bar) and PlxnD1-/- (open bar). 
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Figure 2.10. B cell contribution in WT and PlxnD1-/- GCs.  
(A) GCs in both WT and PlxnD1-/- mice are made up of donor B cells as measured by 
histology. Five mm sections of spleens from WT and PlxnD1-/- mice at d14 post 
immunization were labeled with CD45.1 PE (red), CD45.2-AF405 (blue) and GL-7-FITC 
(green) antibodies. FITC signal was amplified using anti-FITC-AF488 Ab. n=5 mice per 
group. (B) GCs in both WT and PlxnD1-/- contain light zones and dark zones. Five mm 
sections of spleens from WT and PlxnD1-/- mice at d14 post immunization were labeled with 
IgD-PE (red), CD21-AF405 (blue) and CD45.2-FITC (green) antibodies. FITC signal was 
amplified using anti-FITC-AF488 Ab. n=5 mice per group. Data are representative of three 
independent experiments. 
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Figure 2.11. Normal Igλ  and Igκ  B cell repertoire in PlxnD1-/- mice.  
(A) Splenocytes were harvested from WT and PlxnD1-/- mice and analyzed by flow 
cytometry. Monoclonal Abs to B220, Igλ and Igκ were used to determine the percentages of 
Igλ and Igκ splenic B cell among total splenocytes. Plots are pre-gated on live CD45.2+ 
splenocytes. Data are representative of 4-5 mice for each genotype. Data are representative of 
two independent experiments. Mean percentage ± SEM is indicated for each cell type. Total 
numbers of cells are expressed in the corresponding graphs. WT (solid bar) and PlxnD1-/- 
(open bar). (B) Five mm sections of spleens from WT and PlxnD1-/- mice were labeled with 
B220 PE (red), Igκ-AF405 (blue) and Igλ-FITC (green) antibodies. FITC signal was 
amplified using anti-FITC-AF488 Ab. n=4 mice per group. (C) Five mm sections of spleens 
from day14 NP-CGG immunized WT and PlxnD1-/- mice were labeled with IgD PE (red), 
Igκ-AF405 (blue) and Igλ-FITC (green) antibodies. FITC signal was amplified using anti-
FITC-AF488 Ab. n=5 mice per group. Data are representative of two independent 
experiments.  
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Figure 2.12. Normal IgM AFC responses in PlxnD1-/- mice.  
Antigen specific AFC formation in WT (solid bar) and PlxnD1-/- (open bar) mice. Spleens 
were harvested at day 5 and 14 post-immunization. NP-specific and total IgM AFCs were 
enumerated by ELISPOT on wells coated with NP25-BSA. Data were pooled from three 
independent experiments. Mean±SEM. n=10.  
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Figure 2.13. Normal Ti immune responses in PlxnD1-/- mice.  
Mice were immunized (ip) with 25 µg NP-Ficoll in PBS. Serum was harvested prior to 
immunization, 3 and 5 days post immunization. Ab levels were measured by ELISA using 
NP25-BSA as capture antigens. WT (solid circle) and PlxnD1-/- (open circle). NP-specific Ab 
was detected using goat anti-mouse IgM Ab. Data are representative of two independent 
experiments. Small horizontal bars indicate mean values. Each circle is representative of one 
individual mouse.  
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3.1 ABSTRACT 
 
The plexin gene family is implicated in cellular movement and cell-cell communication 
during the course of the immune response. In this study, we characterize the expression and 
function of plexin-D1 in the immune system. We show that plexin-D1 is highly expressed in 
DP thymocytes and dendritic cells (DCs). Absence of Plexin-D1 resulted in aberrant thymic 
development and impaired DP thymocyte migration from the cortex to the medulla. 
However, the absence of plexin-D1 did not affect mature T cell development and peripheral 
T cell responses to CFA-KLH challenge. We did not find a role for plexin-D1 in autoimmune 
disease development as assessed by increased T cell activation and B cell responses.  
PlxnD1-/- DCs and wild-type DCs upregulated costimulatory molecules and activated antigen 
specific T cells in an indistinguishable fashion. These data indicate that Plexin-D1 is 
important in early thymic development but does not affect the measured peripheral T cell and 
DC responses.  
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3.2 INTRODUCTION 
Semaphorins and plexins were initially identified as key molecules in axon guidance 
during neuronal development (Kolodkin, Matthes et al. 1993; Winberg, Noordermeer et al. 
1998). Semaphorins are classified into three different groups based on their origin and 
structural homology; invertebrate, vertebrate and viral semaphorins (Mizui, Kumanogoh et 
al. 2009). Plexin receptors are divided into two large groups, invertebrate and vertebrate, and 
further subdivided into four different families, A-D (Takamatsu, Okuno et al.). Although 
plexins are considered receptors for the semaphorin ligands, this view is recently being 
revised as semaphorins are shown to also mediate signal transduction (Tamagnone, Artigiani 
et al. 1999; Castellani and Rougon 2002; Kruger, Aurandt et al. 2005; Yazdani and Terman 
2006). The interactions between semaphorins and plexins are promiscuous because 
semaphorins can interact with multiple plexins on multiple cell types and vice versa 
(Takamatsu, Okuno et al.). Plexins and semaphorins control cell movement and migration 
and are implicated in vasculature formation as well as organ development (Sakurai, Gavard 
et al. ; van der Zwaag, Hellemons et al. 2002; Gu, Yoshida et al. 2005; Choi, Duke-Cohan et 
al. 2008).  
Recent work has implicated plexins and semaphorins in the immune system 
(Granziero, Circosta et al. 2003; Wong, Brickey et al. 2003; Walzer, Galibert et al. 2005; 
O'Connor, Eun et al. 2008; Suzuki, Kumanogoh et al. 2008; Yamamoto, Suzuki et al. 2008). 
Several plexins and semaphorins are expressed by naïve and activated immune cells. For 
example plexin-D1 and semaphorin 3E are expressed in the thymus where their interaction is 
required for proper thymocyte trafficking (Choi, Duke-Cohan et al. 2008). A number of 
studies have focused on expression of plexins and semaphorins on subsets of DCs and T 
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cells. For example, plexin-A1 and semaphorin6D are respectively expressed on DCs and 
activated T cells (Wong, Brickey et al. 2003; O'Connor, Eun et al. 2008) and they regulate 
different aspects of the DC-T cell interaction during the course of T cell activation.  
Expression of a number of plexins and semaphorins is associated with an activated cell 
phenotype. Semaphorin4A is expressed by Th1 polarized T cells and DCs (Kumanogoh, 
Marukawa et al. 2002); semaphorin4D is expressed by T cells, DCs, and activated B cells 
(Delaire, Elhabazi et al. 1998; Kumanogoh, Watanabe et al. 2000; Shi, Kumanogoh et al. 
2000; Kumanogoh, Suzuki et al. 2002; Granziero, Circosta et al. 2003; Kumanogoh, Shikina 
et al. 2005); and plexin-B2 is expressed by germinal center B cells (Yamamoto, Suzuki et al. 
2008). The studies of semaphorin and plexins expression in the immune system extend to a 
number of other cell types and are carefully reviewed in (Mizui, Kumanogoh et al. 2009). 
These studies suggest that immune plexin and semaphorin expression is spatiotemporally 
regulated as they are expressed by a large number of immune cells at different activation 
states. As a result, a high degree of cooperation between plexins and semaphorins is 
expected, as is some redundancy.  
Given the high level of plexin and semaphorin expression by a variety of immune 
cells, a number of studies have been performed in order to address the physiological 
relevance of these molecules.  Work in our laboratory has defined a role for plexin-A1 
expression on DCs. This molecule is required for proper T-cell activation and proliferation 
(Wong, Brickey et al. 2003; Eun, O'Connor et al. 2006). Semaphorin6D, a known ligand for 
plexin-A1, is expressed on activated T cells and is required for late-phase T cell proliferation 
(O'Connor, Eun et al. 2008). The role of plexin molecules in T cell immune responses 
extends to Plexin-A4 (Yamamoto, Suzuki et al. 2008). Mice deficient in plexin-A4 develop 
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exacerbated MOG-induced experimental autoimmune encephalomyelitis (EAE) (Yamamoto, 
Suzuki et al. 2008). Semaphorin7A binds to α1β1 integrin and promotes T-cell-mediated 
immune responses such as contact hypersensitivity (Czopik, Bynoe et al. 2006; Kang, Lee et 
al. 2007; Suzuki, Okuno et al. 2007). Semaphorin4A is required to promote Th1 immune 
responses (Kumanogoh, Marukawa et al. 2002). Semaphorin4D maintains B-cell homeostasis 
and facilitates humoral immune responses(Kumanogoh, Watanabe et al. 2000; Shi, 
Kumanogoh et al. 2000; Kumanogoh, Suzuki et al. 2002; Kumanogoh, Shikina et al. 2005). 
Together, these studies suggest that plexin and semaphorins are indispensable for initiation 
and maintenance of a number of immune responses.  
Another member of the plexin family of molecules, plexin-D1, was recently shown to 
be expressed by DP thymocytes and facilitate their migration from the cortex into the 
medulla (Choi, Duke-Cohan et al. 2008). However, the role of plexin-D1 in peripheral T cell 
development and function remains unexplored. To date, plexin-D1 research in the immune 
system has been limited. Future studies addressing the role of plexin-D1 in T cell immunity 
would help our understanding of plexin-D1-mediated immune cell migration and activation. 
Plexin-D1 partners with two different semaphorin molecules: semaphorin3E and 
semaphorin4A in non-immune cells (Gu, Yoshida et al. 2005; Toyofuku, Yabuki et al. 2007). 
However, semaphorin3E is the only plexin-D1 partner identified in the immune system 
(Choi, Duke-Cohan et al. 2008).  
Successful T cell development and selection in the thymus is critical for both cellular 
and humoral immunity. Thymocytes undergo a series of developmental stages where they 
interact with thymic epithelial cells and DCs in order to be negatively and positively selected 
(Anderson and Jenkinson 2001). Selection requires controlled movement of thymocytes from 
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the cortex into the medulla (Benoist and Mathis 1999). Defective migration of thymocytes 
into the medulla can lead to improper thymocyte selection and subsequently result in 
impaired T cell immune responses or development of autoimmune disease (Forster, Schubel 
et al. 1999; Misslitz, Pabst et al. 2004; Ueno, Saito et al. 2004).  
To address the role of plexin-D1 in T cell and DC development and function we 
utilized PlxnD1-/- animals. In this study, we report that plexin-D1 is highly expressed by DP 
thymocytes but not by peripheral naïve and activated T cells. Amond DCs, plexin-D1 is 
highly expressed by conventional DCs but not plasmacytoid DCs, and its expression is 
further  induced post DC activation. We used in vitro and in vivo approaches to examine the 
direct effect of plexin-D1 in T cell and DC immune responses. We found that PlxnD1-/- T 
cells proliferate and produce Th1 and Th2 cytokines similarly to WT T cells, both, in vitro 
and in vivo. DCs lacking plexin-D1 were capable of processing antigen and efficiently 
presenting it to T cells. Together these findings show that plexin-D1 is important for 
thymocyte migration in the thymus but it does not affect peripheral T cell development and 
function that were assayed. Additionally, plexin-D1 is dispensable for DC function. These 
experiments suggest that plexin-D1 might serve redundant functions in mature T cells and 
DCs, functions that are shared with other plexin molecules.  
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3.3 RESULTS 
Plexin-D1 and semaphorin3E expression in the immune system 
A previous study showed that PlxnD1 is expressed by DP thymocytes (Choi, Duke-
Cohan et al. 2008). We extended plexin-D1 expression studies from immature thymocytes to 
mature peripheral T cells using quantitative real-time PCR methods. PlxnD1 mRNA 
expression is minimally detected in peripheral CD4 and CD8 T cells and substantially 
reduced compared to the thymus and DP T cell progenitors (Figure 3.1A). To determine 
whether activation events affect plexin-D1 expression on T cells, we stimulated sorted CD4+ 
T cells with anti-CD3 and anti-CD28 (Th0), anti-IL4 and IL12 (Th1) or anti-IFNγ and IL4 
(Th2) skewing conditions for 72 hours. Additionally, we stimulated sorted CD8+ T cells with 
anti-CD3 and anti-CD28 for 72 hours to obtain activated cells. Th0, Th1, and Th2 as well as 
activated CD8 T cells all expressed little plexin-D1 (Figure 3.1A). These data suggest that 
plexin-D1 expression is confined to immature T cell populations and is not affected by T cell 
activation events.  
We extended plexin-D1 expression studies to another immune cell type, DCs, which 
are required for T cell development and selection in the thymus and T cell priming in the 
secondary lymphoid organs. We observed plexin-D1 expression in sorted splenic myeloid 
DCs (mDCs) (CD11b+CD11c+) and bone marrow-derived DCs, but not in plasmacytoid DCs 
(CD11c+B220+mPDCA1+) (Figure 3.1B). In addition, we activated DCs with various TLR 
ligands and anti-CD40 Ab and assessed plexin-D1 expression. Our data shows that plexin-D1 
is expressed in resting DCs of both spleen and BM origin and further upregulated post TLR 
ligand stimulation.  
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Given the high expression of plexin-D1 in the thymus by RT-PCR, we assessed 
PlxnD1 expression in the intact thymus of naïve C57BL/6 mice by in situ hybridization to 
confirm plexin-D1 transcript localization. As seen in Figure 3.1C, the predominant PlxnD1 
mRNA staining was localized to the cortex and the cortex/medulla border in the thymus. 
These findings are in line with reports of another group (Choi, Duke-Cohan et al. 2008). 
Other studies have shown that the predominant plexin-D1 partner in the immune 
system is semaphorin3E (Choi, Duke-Cohan et al. 2008). However, these studies do not 
analyze semaphorin3E expression on specific immune cell populations. We analyzed 
semaphorin3E expression in a number of immune cells (Figure 3.1D). Our data show that 
semaphorin3E is minimally detected in naïve and activated T and B cell populations. 
However, semaphorin3E is highly expressed on Th2 skewed T cells and splenic mDCs. The 
expression pattern of semaphorin3E suggests that partnering of this molecule with plexin-D1 
during the course of an immune response may be important for T cell activation and 
potentially for skewing to a Th2 effector response. 
 
PlxnD1-/- mice exhibit compromised thymic architecture 
Given that plexin-D1 is highly expressed in the thymus, we assessed the effect that 
absence of plexin-D1 has on thymic development. PlxnD1-/- animals die shortly after birth 
thereby preventing the study of intact thymus development later than E19 (Gu, Yoshida et al. 
2005). We isolated fetal thymii from embryonic day 19 (E19) animals and observed a 
reduced size of PlxnD1-/- thymii compared to WT mice (Figure 3.2A). PlxnD1-/- thymii also 
differed in the shape from WT thymii as they do not appear round.   
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To further assess whether the size and shape of plexin-D1-deficient thymii affected 
lymphocyte development in these mice, we performed fetal thymic organ cultures (FTOC). 
We isolated fetal thymii from E14 animals and cultured them for 7 days before assessing the 
percentages of thymocytes and T cells present. PlxnD1-/- thymii gave rise to similar 
percentages of single positive CD4 and CD8 thymocytes (Figure 3.2B). These data suggest 
that despite the reduced size and abnormal shape of PlxnD1-/- thymii, single positive T cells 
are produced. 
 The FTOC system is an in vitro cell culture system, thus, assessment of thymocyte 
development in vivo was imperative. Given that PlxnD1-/- mice die shortly after birth we 
created chimeric PlxnD1-/- animals where hematopoietic cells from E14 fetal livers were 
transferred into lethally irradiated congenic mice. This method allowed us to study plexin-
D1-deificent thymocyte development post birth. We isolated thymii from chimeric PlxnD1-/- 
mice 4-6 weeks post fetal liver cell transfer. The thymii were then sectioned and stained with 
CD4, CD8, and CD69 antibodies to determine distribution of thymocytes in the cortex and 
medulla. As shown in Figure 3.2C, thymii of PlxnD1-/- reconstituted mice exhibit an 
abnormal distribution of activated CD69+ thymocytes in the cortex of the thymus. Previous 
studies have reported that activated thymocytes can induce thymic medulla formation in the 
thymus (Shores, Van Ewijk et al. 1994). We assessed whether activated thymocytes of 
PlxnD1-/- mice induce medullary structures in the cortex. As shown in Figure 3.2D, the 
frequency of large medullary structures found in the cortex of PlxnD1-/- mice is higher than 
that found in WT animals. These data suggest a role for plexin-D1 in proper cortex-medulla 
separation and therefore, potential importance in T cell development.  
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PlxnD1-/- T cells exhibit normal in vitro and in vivo activation profiles 
To determine if the absence of plexin-D1 affects T lymphocyte development in the 
periphery, C57BL/6 CD45.1 mice were reconstituted with either WT or PlxnD1-/- fetal liver 
cells. Donor and recipient hematopoietic cell populations were distinguished based on the 
expression of the CD45.1 (host) or CD45.2 (donor) congenic markers. We analyzed the T 
cell compartment in PlxnD1-/- and WT mice. CD4-CD8- (DN), CD4+CD8+ (DP), and CD4+ or 
CD8+ (SP) thymocytes and mature CD4 and CD8 T cells in the spleen were equivalent in 
PlxnD1-/- and WT animals (Figure 3.3A). The PlxnD1-/- and WT T cells had similar levels of 
CD3, TCR-β and CD28 (data not shown).   
We next determined the function of mature T cells. Splenic T-cell proliferation in 
response to anti-CD3 was examined by 3H thymidine incorporation. PlxnD1-/- T cells 
proliferated to levels comparable to the WT controls (Figure 3.3B). Sorted CD4+CD62Lhi 
naïve T cells were cultured under Th1 or Th2 skewing conditions. Activated PlxnD1-/- CD4+ 
T cells were able to produce similar levels of IL-2, IFNγ, and IL-4 as WT animals (Figure 
3.3C). These data suggest that despite impaired thymic migration, once the T cells have 
egressed from the thymus, PlxnD1-/- CD4+ T cells can produce comparable levels of Th1 or 
Th2 cytokines.  
We immunized PlxnD1-/- and WT mice with the antigen KLH in the presence of CFA 
as well as control OVA-CFA and isolated splenocytes 8 days post immunization. We 
performed in vitro KLH re-challenge of isolated T cells and assessed T cell proliferation 
using 3H-Thymidine incorporation. As shown in Figure 3.4A, T cells exhibit normal 
proliferative capabilities as compared to WT controls. We assessed T cell cytokine release 
post in vitro recall responses with KLH. As shown in Figure 3.4B, WT and PlxnD1-/- 
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animals were able to produce similar percentages of activated T cells as assessed by CD44 
expression. CD44+ T released similar levels of IFNγ and IL2 cytokines.  
These data suggest that plexin-D1 does not affect peripheral T cell function as 
assessed by T cell proliferation, costimulatory molecules surface expression and Th1 vs. Th2 
cytokine release in response to antigenic simulation.  
 
PlxnD1-/- mice do not display signs of autoimmunity when aged 
Based on our thymus organization data and previous work published on migration of 
PlxnD1-/- DP thymocytes, we tested the hypothesis that PlxnD1-/- thymocytes might not 
undergo proper thymic education and lead to autoimmunity in aged PlxnD1-/- mice. To this 
end, we aged PlxnD1-/- animals for 12-14 months and evaluated whether these mice develop 
autoimmune diseases.  
The development of many spontaneous systemic autoimmune diseases is dependent 
on chronic activation of T cells (Yagi, Matsumoto et al. 1992; Adachi, Inaba et al. 1998). 
Upregulation of CD44 and downregulation of CD62L are both indicators of T cell activation 
and potentially T-cell mediated autoimmunity (Chu, Ernst et al. 1994). We assessed CD44 
and CD62L surface expression on PlxnD1-/- and WT T cells by flow cytometry. Our data 
show that percentages of effector and memory T cells in the spleen were comparable between 
PlxnD1-/- mice and WT mice (Figure 3.5A, B). Another marker of autoimmune diseases is 
the presence of anti-dsDNA autoantibody in the serum (Yagi, Matsumoto et al. 1992). 
Individual serum samples were obtained from 12-14 month old PlxnD1-/- and WT animals 
and were tested for the presence of anti-dsDNA autoantibody by ELISA. We did not detect 
anti-dsDNA autoantibody in the PlxnD1-/- and WT animals (data not shown).  
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Our previous work shows a role for plexin-D1 in B cell development and humoral 
immunity. MZ B cells are a reservoir of autoreactive B cell clones (Martin and Kearney 
2002). If PlxnD1-/- mice were prone to autoimmune disorders we would expect an expansion 
of the MZ B cell repertoire. Here we analyzed the MZ B cell compartment in 12-14 month 
old PlxnD1-/- mice. Surprisingly, we observed an almost complete ablation of the MZ B cell 
compartment in aged PlxnD1-/- mice compared to WT mice (Figure 3.5C). This finding 
extends our previous work where we had observed a reduction in the percentages of MZ B 
cells in 6-10 week old PlxnD1-/- animals compared to WT mice. However, the reduction of 
MZ B cells is much more dramatic in aged mice. Together these findings suggest that plexin-
D1 is required for MZ B cell homeostasis through out the lifespan of the mice. Additionally, 
the MZ B cell compartment in PlxnD1-/- mice would not contribute to development of 
autoimmune disease.    
Taken together, these data suggest that ablation of plexin-D1 is not sufficient to 
induce autoimmune manifestations regardless of the impaired thymocyte migration 
phenotype observed in the absence of plexin-D1.  
 
Plexin-D1 is not required for DC development  
Given the expression of plexin-D1 on DCs and its further upregulation post 
stimulation, we studied DC development in the absence of plexin-D1. We assessed DC 
development in the spleen based on expression of CD11c, CD11b and B220. The percentages 
and numbers of mDCs found in the spleen were equivalent between WT and PlxnD1-/- mice 
(Figure 3.6A). We also determine DC formation in vitro from bone marrow progenitors of 
WT and PlxnD1-/- reconstituted mice. In the presence of GMCSF and IL4 PlxnD1-/- DCs 
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develop similarly to WT controls (data not shown). Taken together these data suggest that 
plexin-D1 is not required for development of DCs. 
 
PlxnD1-/- DCs are capable of responding to stimuli and producing cytokines to similar 
levels as WT controls.  
To further assess development of PlxnD1-/- DCs, we stimulated BMDCs from both 
PlxnD1-/- and WT animals with LPS. We determined expression of co-stimulatory molecules 
on the surface of DCs. As shown in Figure 3.6B, CD40, CD80, CD86 and I-Ab surface 
levels were equivalent between WT and PlxnD1-/- mice at the basal level and post activation. 
Supernatants were collected from the different treatments of DC cultures and the levels of 
cytokines released were measured by ELISA. We determined the levels of IL6, TNFα, and 
IL12p40 cytokines in these cultures. As shown in Figure 3.6C, the IL-6, TNFα and IL12p40 
cytokine levels released by cultured DCs were also comparable between WT and PlxnD1-/- 
cells.  
Taken together, these data suggest that despite expression of plexin-D1 by the DC 
population and its upregulation post activation, this molecule is not required for upregulation 
of costimulatory molecules on the surface of activated DCs and for cytokine production by 
the DCs.  
 
PlxnD1-/- DCs stimulate T cells similarly to WT  
To further define the role of plexin-D1 in DCs, we performed an in vitro antigen 
presentation assay using transgenic T cells specific for ovalbumin (OVA), OTII T cells. First 
we determined the ability of plexin-D1-deficient DCs to take up OVA-protein. DCs were 
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culture for 2 hours in the presence of FITC-labeled OVA protein and the amount of OVA 
taken up by DCs was assessed by flow cytometry. PlxnD1-/- and WT DCs take up antigen 
equivalently as shown by the level of mean fluorescence intensity of the analyzed DCs 
(Figure 3.7A). To determine the ability of the DCs to stimulate T cells, freshly isolated 
CFSE-labeled OTII T cells were cultured in the presence of OVA protein-pulsed PlxnD1-/- 
and WT splenic DCs for 3 days. Non OVA-pulsed DCs were used as a negative control. 
Proliferation of Vβ5+ OTII T cells was assessed by flow cytometry. As shown in Figure 
3.7B, plexin-D1-deficient DCs are capable of stimulating T cells similarly to WT. These data 
suggest that plexin-D1 is dispensable during in vitro activation of T cells by the DCs.  
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3.4 DISCUSSION 
Thymocyte migration and selection events are important in ensuring proper T cell 
activation in the periphery. Recent studies using PlxnD1-/- mice have suggested that the 
plexin-D1-Semaphorin3E interaction is essential for thymocyte migration and possibly 
selection. In this study, we characterize the expression of plexin-D1 and semaphorin3E in 
various immune cell types and further determine the role of plexin-D1 in T cell immune 
responses.  
Plexin-D1 is highly expressed by DP thymocytes and myeloid DCs. While its 
expression is downregulated with T cell maturation and activation, expression by DCs is 
increased when these cells are activated and matured in the presence of TLR agonists. 
Expression studies of a plexin-D1 ligand, semaphorin3E, revealed that semaphorin3E is 
highly expressed by Th2-type T cells and DCs. Based on differential expression of plexin-D1 
in lymphoid organs, we hypothesized that in the thymus, absence of plexin-D1 would lead to 
abnormal T cell development. In the periphery, plexin-D1 might be required for T cell-DC 
interactions.  
Although a role for plexin-D1 in the thymocyte migration has been previously 
reported, these studies do not address the role of plexin-D1 in T cell development and 
activation during immune responses. We demonstrate that PlxnD1-/- thymii fail to develop 
normally. Absence of plexin-D1 in DP thymocytes leads to formation of medullary like 
structures in the cortex. Our analysis of PlxnD1-/- mice did not reveal a role for plexin-D1 in 
peripheral T cell development and proliferation. PlxnD1-/- is dispensable for Th1 and Th2 
cell polarization as assessed by IFNγ and IL4 production.  
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Proper thymocyte migration from the cortex into the medulla ensures central 
tolerance (Ueno, Saito et al. 2004). T cells are implicated in a series of autoimmune disorders 
(Yagi, Matsumoto et al. 1992; Adachi, Inaba et al. 1998). For example, mice lacking the 
Ccr7 gene and display impaired thymocyte migration develop symptoms of autoimmune 
disease (Forster, Schubel et al. 1999; Ueno, Saito et al. 2004). An increase in CD44 
lymphocyte expression is considered a marker of autoimmune disease (Estess, DeGrendele et 
al. 1998). For example, spontaneous autoimmune disease in the MLRlpr/lpr mouse strain is 
accompanied by an increase in percentages of activated T cells expressing high levels of 
CD44 (Budd, Schumacher et al. 1991). Absence of plexin-D1 does not result in increased 
percentages of CD44+ T cells in young or aged mice.  
A number of other plexin and semaphorin molecules are shown to control 
development of EAE (Czopik, Bynoe et al. 2006; Yamamoto, Suzuki et al. 2008). Future 
autoimmune disease models, such as EAE, would be important in establishing a role for 
plexin-D1 in autoimmune disease development. T cells are key mediators of EAE. It is 
possible that improper thymic development of PlxnD1-/- T cells could results in accelerated 
EAE.  
Many autoimmune diseases are attributed to B cell hyperproliferation and 
hyperactivation (Wither, Roy et al. 2000; Segundo, Rodriguez et al. 2001; Groom, Kalled et 
al. 2002). We have recently shown that plexin-D1 is important for establishment of the GC 
reaction and subsequently controls recall humoral responses. Impaired T cell selection can 
lead to aberrant B cell responses and subsequently to development of autoimmune disease 
(Budd, Schumacher et al. 1991). We did not observe anti-dsDNA antibodies, a hallmark of 
autoimmune disorders, in the serum of PlxnD1-/- mice. MZ B cells are rapid responders to 
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antigen challenge and have been implicated in several autoimmune disorders (Martin and 
Kearney 2002). MZ B cell are enriched with self-reactive clones in autoimmune mice 
(Wellmann, Werner et al. 2001). Indeed, the MZ B cell compartment expands in NZB/NZW 
lupus-prone mice prior to disease onset. Interestingly, assessment of the B cell repertoire 
revealed an almost complete ablation of MZ B cells in aged PlxnD1-/- mice. These data point 
to a role for plexin-D1 in homeostasis of MZ B cells. Plexin-D1 may be needed to provide 
survival signals to the MZ B cells or it could be required for their ability to adhere to splenic 
stroma. Taken together, these data show that PlxnD1-/- mice do not develop spontaneous 
autoimmune disorders. In fact, these mice show a reduced MZ B cell compartment. These 
findings suggest a role for plexinD1 in regulation of immune responses in aging mice. This 
work could have further implications on targeting of plexinD1 in older individuals in order to 
promote robust immune responses.  
Our studies showed that plexin-D1 is expressed by DCs and further upregulated post 
DC activation. The T cell-DC interaction is important for T cell selection in the thymus and 
initiation of immune responses in the periphery. We assessed the role of plexin-D1 in DC 
development, activation and function. Our results show that plexin-D1 is not required for 
initial DC development and in vitro T cell activation. A number of different plexin molecules 
control DC responses (Wong, Brickey et al. 2003; Eun, O'Connor et al. 2006) and some 
degree of cooperation and functional redundancy is expected amongst plexins. Future studies 
of plexin-D1 deficient DCs are needed in order to define the importance of this molecule in 
DC biology.  
100 
 
3.5 MATERIALS AND METHODS 
Mice  
C57BL/6 and congenic C57BL/6 CD45.1 mice were obtained from the National 
Cancer Institute (Boston, MA). PlxnD1+/- mice were a gift from Dr. Thomas Jessell’s 
laboratory and have been described in (Gu, Yoshida et al. 2005). OT-II mice 
(B6.Cg.Tg(TcrαTCRβ)425Cbn/J), specific for the ovalbumin residue 323-339, were obtained 
from the Jackson Laboratory (Bar Harbor, ME). Mice were housed in a pathogen-free barrier 
facility at University of North Carolina. These studies were approved by the University of 
North Carolina Animal Care and Use Committee. 
For fetal liver chimeras PlxnD1+/- mice were crossed for over 10 generations with 
C57BL/6 mice and intercrossed to obtain PlxnD1-/- and PlxnD1+/+ embryos. PlxnD1+/+ and 
PlxnD1-/- fetal livers were prepared from E14 embryos post PCR genotyping as previously 
described (Gu, Yoshida et al. 2005). Fetal liver cells were then injected (iv) into lethally 
irradiated C57BL/6 CD45.1 mice. Mice were analyzed 6-10 weeks post reconstitution.  
 
ELISA  
 Autoantibodies: Sera was obtained from 12-14 month old naïve mice and was tested for 
anti-dsDNA autoantibodies (IgG, IgM, and IgA) by ELISA (Alpha Diagnostic, San Antonio, 
TX). Standards, negative, and positive control samples were provided in the kit and were run 
concurrently according to manufacturer’s protocol. DC cytokine release: DCs were obtained 
from PlxnD1-/- and WT animals and stimulated for 24 hours in the presence of 1µg/ml anti-
CD40 or 50ng/ml LPS. The culture supernatants were tested for IL6, TNFα, and IL12p40 
cytokine levels by ELISA (Ebioscience, San Diego, CA).  
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In Situ Hybridization 
Naïve C57BL/6 animals were perfused with PBS and thymii were collected and 
embedded in OCT compound, snap frozen, and stored at -80°C. The thymii were then cut 
and fixed in 4%PFA at room temperature for 15 minutes and processed for in situ 
hybridization by the UNC neuroscience center and in-situ hybridization core. To detect the 
PlxnD1 transcript, we used a digoxygenin labeled probe followed by an anti-digoxygenin 
alkaline phosphotase labeled detection antibody.  Nitro-Blue Tetrazolium Chloride/ 5-
Bromo-4-Chloro-3'-Indolyphosphate p-Toluidine Salt (NBT/BCIP) was used to visualize the 
PlxnD1 transcript.  
 
Antibodies and FACS  
Monoclonal Abs included: B220 (RA3-6B2), CD23 (B3B4) and APC-Alexa750-
conjugated streptavidin from BD Pharmingen (San Diego, CA); CD45.2 (104), CD4 (L3T4), 
CD8 (Ly-2), IFNγ (XMG1.2), IL2 (JES6-5H4), IL4 (11B11), CD3 (145-2C11), CD28 
(37.51), CD62L (MEL-14), GL7 (Ly-77), CD11b (M1/70), CD11c (N418), CD21 (eBio8D9) 
and TCRβ (H57-597) from eBioscience (San Diego, CA). Secondary antibodies included 
anti-FITC-Alexa488 and Alexa350-conjugated streptavidin from Invitrogen (Raleigh, NC). 
Single cell suspensions of different tissues were counted and 106 cells were suspended in 
FACS buffer (1xPBS plus 2% FBS) and stained with various antibody combinations. All 
flow cytometry was performed on a FACSCalibur or LSRII cytometer (BD Biosciences) and 
analyzed with FlowJo software (Tree Star). Cell sorting was performed on a MoFlo 
cytometer (Beckman-Coulter).  
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RT-PCR and Quantitative RT-PCR analysis  
RNA was isolated from tissues or sorted resting cell populations (CD62Lhi CD4+ T 
cells, CD62LhiCD8+ T cells) as well as Th0, Th1 and Th2 cells using a Qiagen RNA 
extraction kit. cDNA was synthesized using SuperScript III reverse transcriptase 
(Invitrogen). Primers used for RT-PCR and real-time PCR analysis were: HPRT, 5’-
GCTGGTGAAAAGGACCTCT-3’, 5’-CACAGGACTAGAACA CCTGC-3’; PlxnD1, 5’-
CCTGGGTCACCTCTGTGTTT-3’, 5’-TATCTGTCAGGCAGGGGTTC-3’; and 
Semaphorin3E, 5’-AGGCCCTGAATACCACTGGTC-3’, 5’-
GGTTCCTGTGCCAGCAAAGT-3’. Quantitative real-time PCR was performed using 
SYBR Green reagent in a BIORAD iCycler.  
 
Cell culture  
Proliferation assays: Sorted CD62Lhi CD4+ and CD62Lhi CD4+ naive splenic T cells 
(2x106 cells/ml) were cultured for 3 days with immobilized anti-CD3 (5µg/ml) and anti-
CD28 (5µg/ml) in RPMI media (Gibco) containing 10% FBS, 10-4M 2-ME and 
penicillin/streptomycin (P/S) antibiotics in 96 well plates. One µCi of 3H thymidine was 
added to the cultures for the last 8 hours to assess proliferation. T cell activation: Th1 vs. Th2 
skewing was conducted as follows. Sorted CD62Lhi CD4+ naive splenic T cells (2x106 
cells/ml) were cultured for 3 days with immobilized anti-CD3 (5µg/ml) and anti-CD28 
(5µg/ml) in the presence of anti-IL4 (10µg/ml) and IL-12 (10ng/ml) (Th1-skewing 
conditions) or in the presence of anti-IFNγ (10µg/ml) and IL-4 (10ng/ml) (Th2-skewing 
conditions). Cells were then assessed for cytokine production using intracellular staining and 
flow cytometry. DC culture: Murine bone marrow DCs were isolated from WT and PlxnD1-/- 
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mice and were cultured in the presence of GM-CSF and IL-4 as previously described (van 
Deventer, Serody et al. 2002). T cell culture: T cells from OT-II mice and purified by 
negative selection (STEMCELL). DC:T cell co-cultures: DCs were harvested at day 10 and 
pulsed overnight with 50µg/ml OVA (Sigma-Aldrich). 200,000 DCs were then washed and 
cultured in a 1:10 ratio with T cells from OT-II transgenic T cells in 6 well plates.  
 
Histology  
Thymii from naïve and immunized mice were embedded in OCT compound, snap 
frozen, and stored at -80°C. 5 mm sections were prepared and fixed with 1:1 
Acetone:Methanol for 10 min at -20°C and labeled with various combinations of 
fluorescently labeled TCRβ, CD4, CD8 and CD69 mAb. FITC signal was amplified using 
anti-FITC-Alexa488 mAb. Streptavidin-AlexaFluor350 or Streptavidin-AlexaFluor405 was 
used to amplify -biotin signal (blue). Images were acquired using a Zeiss Axiovert 200M or 
Zeiss LSM 710 confocal immunofluorescent microscope. 
 
Statistical analysis 
Statistical significance was determined with two-tailed Student’s t test. All p values 
less than 0.05 were considered significant.  
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Figure 3.1. Plexin-D1 expression. (A) Expression of PlxnD1 in the thymus, DN and DP 
thymocytes, SP thymocytes and activated CD4 and CD8 T cells as measured by real-time 
PCR. Data are representative of three independent experiments. (B) Expression of PlxnD1 in 
sDCs, BMDC D6 and D10, and activated BMDC as measured by real-time PCR. Data are 
representative of three independent experiments. (C) Expression of PlxnD1 as measured by 
in situ hybridization. In situ hybridization was performed using a digoxygenin labeled probe 
recognizing PlxnD1 mRNA (bp 1750-2468) on 6-8 week old C57BL/6 thymus sections. Data 
representative of 2 independent experiments. (D) Expression of Semaphorin3E in sorted 
naïve and activated T cell and B cell populations, and DCs. Data are representative of 3 
independent experiments.  
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Figure 3.2. Abnormal thymic architecture and medullary structure formation in the 
absence of plexin-D1. (A) Thymii were collected from E19 embryos and images were 
acquired using a digital camera. Images are representative of 5 different experiments. n=8-10 
mice per group. (B) Thymii were collected from E14 embryos and cultured for 3 days. Single 
cells suspensions were prepared and analyzed by flow cytometry using anti-CD4 and -CD8 
mAbs. (C) Five mm sections of thymii from WT and PlxnD1-/- chimeric mice were labeled 
with CD8-AF405 (blue), CD4-PE (red) and CD69-FITC (green) antibodies. FITC signal was 
amplified using anti-FITC-AF488 Ab.  Images were acquired using a Zeiss Axiovert 200M 
confocal immunofluorescent microscope. n=10 mice per group. (C) Five mm sections of 
thymii from WT and PlxnD1-/- chimeric mice were labeled with CD8-AF405 (blue) and 
CD69-FITC (green) antibodies. FITC signal was amplified using anti-FITC-AF488 Ab.  
Images were acquired using a Zeiss Axiovert 200M confocal immunofluorescent 
microscope. n=10 mice per group. 
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Figure 3.3. Normal reconstitution and in vitro function of PlxnD1-/- T cells 
(A) Thymus and spleen cells were harvested from PlxnD1-/- and WT mice and analyzed by 
flow cytometry. Monoclonal Ab to CD45.1, CD45.2, CD4, and CD8 were used to stain 
different T cell progenitors and mature T cells in the thymus (top) and spleen (bottom). Data 
are representative of 3 different experiments. n=12 mice per group. (B) CD62LhiCD4+ T cells 
were purified and cultured for 72 hours with anti-CD3. Cells were pulsed with 3H thymidine 
for the last 8 hours in culture to determine cell proliferation and data are presented as counts 
per minute (c.p.m). Data are representative of 3 different experiments. n=9 mice per group. 
(C) CD62LhiCD4+ T cells were purified and cultured for 72 hours with anti-CD3/anti-CD28 
in the presence of Th1 or Th2 skewing conditions. IL2, IFNγ and IL4 cytokine production 
were assessed by intracellular staining. Data are representative of 3 different experiments. 
n=9 mice per group.  
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Figure 3.4. Normal recall responses of PlxnD1-/- T cells. (A) Chimeric WT and PlxnD1-/- 
mice were immunized with KLH-CFA, OVA-CFA, or PBS-CFA and analyzed 7 days post 
immunization. Splenic T cells were isolated and cultured in the presence of DCs and varying 
amounts of KLH for 3 days. CD4 T cell proliferation was assessed via 3H-thymidine 
incorporation. (B) Splenocytes from KLH-CFA immunized mice were cultured in the 
presence of KLH for 6 hours and cytokine production was analyzed by flow cytometry. Data 
are representative of 3 independent experiments. n=8 mice per group.  
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Figure 3.5. Aged PlxnD1-/- animals do not show signs of autoimmunity. Chimeric WT 
and PlxnD1-/- mice were aged for 12-14 months. Splenocytes were isolated and CD4 (A) and 
CD8 (B) effector and memory cells were analyzed by flow cytometry. Data are 
representative of 2 different experiments. N=6 mice per group. (C) Splenocytes were isolated 
and stained with antibodies against B220, CD21, CD23, IgM, and IgD. Cells were anaysed 
by flow cytometry. Data are representative of 2 different experiments. n=6 mice per group.  
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Figure 3.6. PlxnD1-/- DCs develop and function similarly to WT controls. 
(A) Spleens were harvested from PlxnD1-/- and WT mice and splenocytes were analyzed by 
flow cytometry. Monoclonal Ab to CD45.1, CD45.2, CD11b and CD11c were used to stain 
DCs in the spleen. Data are representative of 3 different experiments. n=9 mice per group. 
(B) PlxnD1-/- DCs are able to upregulate cell surface receptors. DCs were derived in the 
presence of GM-CSF and IL4 from the bone marrow of mice reconstituted with PlxnD1-/- 
and WT fetal liver cells. DCs were then cultured in the presence of LPS and cell surface 
receptor expression was assessed 24 hours later using flow cytometry. Data are 
representative of 3 independent experiments. n=9 mice per group. (C) PlxnD1-/- DCs are able 
to produce inflammatory cytokines in response to TLR stimuli and anti-CD40. DCs were 
cultured in the presence of LPS and anti-CD40 for 24 hours. Culture supernatants were 
assessed for cytokine production by ELISA. Data are representative of 3 independent 
experiments. n=9 mice per group. 
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Figure 3.7. PlxnD1-/- DCs efficiently stimulate antigen specific T cells. PlxnD1-/- DCs are 
capable of stimulating T cells and inducing proliferation. (A) OVA uptake for PlxnD1-/- and 
WT DCs. DCs were isolated from spleens of mice reconstituted with PlxnD1-/- and WT fetal 
liver cells and cultured in the presence of OVA-FITC for 2 hours. OVA uptake was assessed 
by flow cytometry. Data are representative of 2 independent experiments. n=6 mice per 
group. (B) DCs were isolated from spleens of mice reconstituted with PlxnD1-/- and WT fetal 
liver cells. DCs were then co-cultured with OTII-specific T cells in the presence of OVA and 
T cell proliferation was assessed by CFSE dilution 72 hours later using flow cytometry. Data 
are representative of 3 independent experiments. n=9 mice per group. 
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The discovery of plexin and semaphorin molecules in the immune system has opened 
several avenues for future research. A large number of these plexin and semaphorin 
molecules remain understudied in the context of immune responses. Research has 
demonstrated that plexins utilize several semaphorin ligands and other receptors on different 
cell types to regulate cellular interactions (Kruger, Aurandt et al. 2005; O'Connor, Eun et al. 
2008; Suzuki, Kumanogoh et al. 2008). The aim of this dissertation is to elucidate the role of 
plexin-D1 in the immune system. Plexin-D1 was chosen for its high expression on immune 
cells, specifically DP thymocytes, B cells and DCs. We examined the role of plexin-D1 
during the course of B and T cell immune responses in PlxnD1-/- mice.  
A major portion of this dissertation demonstrates a role for plexin-D1 in the 
regulation of humoral immune responses. The humoral arm of the adaptive immune system is 
necessary to provide Abs that protect the organism from pathogen encounters, both, in the 
short and long term (Renshaw, Fanslow et al. 1994)).  
As described in chapter 2, plexin-D1 was constitutively expressed by MZ B cells and 
induced upon activation of FO B cells. Given that plexin-D1 expression was associated with 
an activated B-cell phenotype, we further investigated the importance of plexin-D1 in B cell 
immunity. Absence of plexin-D1 did not affect B cell development in the BM or spleen with 
the exception of marginal zone B cell numbers. As a result, we investigated the ability of 
plexin-D1 deficient B cells to produce antibody. At basal level, PlxnD1-/- mice showed 
reduced levels of class-switched IgG1 and igG2 antibodies. Further analysis revealed that 
mice lacking plexin-D1 have reduced GC formation and maintenance. This in turn led to 
impaired antibody recall-responses. To determine if the B-cell phenotype could be rescued 
by the presence of plexin-D1 sufficient B cells we created chimeric animals where 50% of 
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donor cells were of wild-type origin. In vivo, PlxnD1-/- B cells did not migrate into the GC as 
efficiently as WT B cells suggesting that the GC phenotype we observe was B cell specific 
and could not be rescued in the presence of WT T cells. As an analogy to our in vivo 
experiments, we performed in vitro B-cell migration assays. PlxnD1-/- B cells showed 
reduced migration towards GC chemokines; CCL19, CXCL12, and CXCL13. Thus, we 
correlate the impaired GC reaction in PlxnD1-/- mice to the inability of plexin-D1 deficient B 
cells to migrate towards GC chemokines.  
New research avenues and questions arise as a result of these findings. What are the 
patterns of PlxnD1-/- B-cell movement during a Td immune response and the GC reaction? 
What cellular events, in addition to migration, contribute to impaired GC formation? Is the 
pool of memory B cells directly affected by the reduced GC reaction? Are there other 
molecules that interact with plexin-D1 and control Td humoral immune responses, 
specifically the GC reaction? What other molecules does plexin-D1 interact with during the 
Td humoral immune response, specifically the GC reaction?  
 
What are the patterns of PlxnD1-/- B-cell movement during a Td immune response and 
the GC reaction? 
 In chapter 2 we show that plexin-D1-deficient B cells display an impaired ability to 
migrate into the GC. Future work studying the movement of PlxnD1-/- B cells during the 
course of a Td immune response is needed. An extensive study employing two-photon/multi-
photon microcopy to track plexin-D1 deficient B cells could be used to determine whether 
cells enter, but are not retained in, the GC reaction. Using 2-photon or multiphoton 
microcopy, we could track plexin-D1-deficient B cells within the GC and determine 
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whethere PlxnD1-/- B cells i) are able to collaborate with Th cells found in the GC, ii) can 
move between the LZ and DZ, and iii) are able to be retained in the GC.  
 
What cellular events, in addition to migration, contribute to impaired GC formation?  
In part, we attributed impaired GC formation to the inability of PlxnD1-/- B cells to 
migrate into the GC as efficiently as WT B cells This was followed by reduced migration of 
PlxnD1-/- B cells towards GC chemokines. We correlate impaired migration into GC 
reactions with reduced in vitro migration of PlxnD1-/- B cells to chemokines present in GCs. 
However, the in vitro migration defects are incomplete, thus suggesting that plexin-D1 might 
affect other processes required for initiation and maintenance of the GC. B cell proliferation 
and apoptosis are important aspect of GC formation and maintenance (Linterman, Beaton et 
al. ; Zotos, Coquet et al.). For example, studies of IL21-/- mice show reduced GC B cell 
proliferation and subsequently impaired GC maintenance (Linterman, Beaton et al. ; Zotos, 
Coquet et al.). Similar to this work, we would determine proliferation of PlxnD1-/- B cells in 
the GC reaction using BrdU incorporation studies. Although we have not observed 
differences in B cell proliferation in vitro, the GC reaction utilizes a series of cytokines to 
organize cellular compartments in vivo, to drive proliferation. Accordingly, we would expect 
the proliferative response that occurs during the GC reaction to differ from the proliferative 
response observed in vitro with purified B cells.  
Apoptosis is an important aspect of the GC response (MacLennan 1994; Koopman, 
Keehnen et al. 1997; Allen, Okada et al. 2007). Our data does not address whether Plexin-
D1-/- B cells have an increased propensity towards apoptosis. Determining the rate of 
apoptosis between PlxnD1-/- and WT GC B cells would be difficult; however, studies in Bcl-
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XL transgenic PlxnD1-/- mice would help determine whether enhanced apoptosis contributes 
to impaired GC response.  
Cell adhesion is required for proper B cell activation and selection in the GC reaction 
(Koopman, Keehnen et al. 1994; Balogh, Aydar et al. 2002). Examination of adhesions 
molecule expression patterns on PlxnD1-/- GC B cells would provide insight into which 
components are controlled by plexin-D1. This could be achieved via microarray studies, 
followed by real-time RT-PCR and western blot studies. Several groups are interested in the 
role of plexins and the immune system; therefore, we expect a plexin-D1-specific 
monoclonal-Ab to become available. Availability of this monoclonal-Ab against plexin-D1 
will allow biochemical studies to determine interacting partners of plexnD1 following B cell 
activation.  
Plexin molecules act as regulators of Rho family small GTPases to control cell 
movement and adhesion in response to extracellular stimuli (Zanata, Hovatta et al. 2002; 
Oinuma, Katoh et al. 2003; Tong, Chugha et al. 2007; Uesugi, Oinuma et al. 2009). Rnd 
proteins are new members of the Rho family, which lack intrinsic GTPase activities (Nobes, 
Lauritzen et al. 1998). Instead, Rnd proteins partner with other molecules such as p190-
RhoGAP or Pragmin to control Rho family GTPases such as RhoA (Katoh, Harada et al. 
2002; Wennerberg, Forget et al. 2003; Tanaka, Katoh et al. 2006). Rnd proteins also bind the 
cytoplasmic domain of plexin molecules in order to promote semaphoring-plexin signaling. 
For example, plexin-B1 encodes a GTPase-activating protein (GAP) for R-Ras in the 
cytoplasmic domains (Oinuma, Ishikawa et al. 2004). Plexin-B1 partners with Rnd1 in order 
to form a molecular complex that that stimulates the GTPase activity of R-Ras(Oinuma, 
Katoh et al. 2004). This in turn regulates cell migration. Research on plexin-D1 has revealed 
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that this molecule displays R-Ras GAP activity in the presence of Rnd2 and control cell 
movement (Uesugi, Oinuma et al. 2009). The intrinsic R-Ras GAP domains on plexin 
molecules are likely to be a common signaling component that extends to immune cell types 
and is used for plexin signaling during the course of an immune response.  
Interruption of plexin-D1 expression at different time points during the Td B cell 
immune response would help determine whether plexin-D1 is required for initiation or 
maintenance of the GC. Blocking the R-Ras activity of plexin-D1 during B-cell immune 
responses could lead to clues as to how plexin-D1 controls B cell migration. This could be 
accomplished by administration of plexin-D1 blocking agents, such as a plexin-D1-Fc fusion 
protein, at different time points after antigen immunization.  
 
Is the pool of memory B cell directly affected by the reduced GC reaction? 
The GC is the pivotal site of memory B cell formation (McHeyzer-Williams and 
McHeyzer-Williams 2005). How plexin-D1 affects memory B cell development is still under 
investigation. Our work shows a requirement for plexin-D1 in antibody recall responses and 
long-lived BM plasma cell formation. Preliminary studies in our laboratory have shown that 
plexin-D1 does not affect development of antigen specific B cells with a memory phenotype, 
as determined by expression of surface CD38. However, the frequency of these cells is 
reduced in PlxnD1-/-mice compared to WT. The mechanism for this outcome needs to be 
explored in the future. This could be achieved by studying the cell signaling events that take 
place during the GC reaction. For example, GC signaling pathways, such as p53, Bcl-6, and 
Blimp-1 could be examined via Western Blot analysis and Phospho-Flow. We have not 
examined whether PlxnD1-/- memory B cells are capable of functioning similarly to WT 
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cells. Future experiments where memory B cells are transferred into naïve recipients and 
assessed for their ability to expand and respond to antigenic challenge would be particularly 
informative.  
 
Are there other molecules that interact with plexin-D1 and control Td humoral immune 
responses, specifically the GC reaction? 
 To date, two plexin-D1 binding partners have been identified: Sema3E and Sema4A 
(Gu, Yoshida et al. 2005; Toyofuku, Yabuki et al. 2007);however, plexins and semaphorins 
can have multiple interacting partners (Kruger, Aurandt et al. 2005; O'Connor, Eun et al. 
2008; Suzuki, Kumanogoh et al. 2008). Thus, it is possible that Plexin-D1 utilizes different 
semaphorin molecules and/or other ligands at various stages of the immune response. 
Although we have determined the expression pattern of Sema3E (Figure 3.1), further studies 
would help establish whether Sema3E is the plexin-D1 partner during B cell immune 
responses. Plexin-D1 studies in the vascular system have shown that plexin-D1-Sema3E 
partnering can have repulsive or attractive properties in the absence or presence of 
neuropilin-1 binding, respectively (Gu, Yoshida et al. 2005; Toyofuku, Yoshida et al. 2008). 
We hypothesize that during the course of a Td immune response, plexin-D1 utilizes 
different binding partners to coordinate cellular localization. For example, at the initiation of 
the immune response, plexin-D1 could use Sema3E to facilitate B cells migration towards the 
T cell zone. Once B cells have received T cell help, surface plexin-D1 could partner with 
other ligands to force B cell migration back into the B cell follicle and ultimately into the GC 
reaction. Identifying the specific partners for Plexin-D1 will help shed light on the molecular 
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mechanisms that contribute to the B cell response and potentially identify future targets for 
vaccine design.  
 
T cell and DC biology  
As described in chapter 3, plexin-D1-deficient double positive thymocytes exhibited 
impaired migration from the cortex into the medulla. This defect in migration led to 
compromised thymic architecture; however, the absence of plexin-D1 did not affect 
peripheral T-cell development. Independently, Choi et al identified a role of plexin-D1 in T 
cell development in the thymus (Choi, Duke-Cohan et al. 2008). This work demonstrated that 
plexin-D1 was important for thymocyte migration from the cortex into the medulla. These 
studies did not examine the role of plexin-D1 in T cells past the thymic stages of 
development. These authors speculated that PlxnD1-/- mice might foster autoimmunity with 
age, based on previous research with Ccr7-/- mice (Ueno, Saito et al. 2004). Similarly to 
PlxnD1-/- mice, Ccr7-/- mice exhibit abnormal thymic architecture due to impaired migration 
of DP thymocytes into the medulla. Our results presented in Chapter 3 further extend this 
work to determine the functionality of T cell in the periphery.  
PlxnD1-/- T cells responded similarly to WT T cells when activated both in vitro and 
in vivo. Aged PlxnD1-/- mice did not develop autoreactivity as assessed by the normal 
frequency of activated T cells in the spleen, lack of auto-antibodies in the serum, and lack of 
immune complexes deposition in the kidneys of the mice. Although, PlxnD1-/- mice showed 
no obvious signs of autoreactivity, a more extensive study of other organs such as lachrymal 
glands could reveal an autoimmune phenotype. Future studies could also focus on T effectors 
cell development, TCR repertoire and TCR affinity analysis.  
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Many genes that contribute to the development of autoimmune diseases are not 
apparent on the C57BL/6 background. For example, TRAF3-/- mice develop autoimmunity on 
a mixed background such as B6 x 129 (Xie, Stunz et al. 2007). Therefore, it would be 
important to study the effects of plexin-D1 deficiency and its ability to induce autoimmune 
disease on a different genetic background such as the B6 x 129.  
 
DC-T cell interaction 
 Our work in chapters 2 and 3 clearly demonstrates the requirement for Plexin-D1 in i) 
thymocyte movement, ii) in GC development and, iii) humoral recall responses. Thymic T 
cell selection and the GC reaction are complex processes that require DCs for antigen 
presentation and selection (Anderson and Jenkinson 2001; Allen and Cyster 2008). Plexin-
D1 is highly expressed by DCs and its expression is upregulated with activation. As detailed 
in chapter 3, PlxnD1-/- DCs develop similarly to WT DCs. They are capable of activating T 
cells and producing an array of cytokines.  
 Our peripheral T cell and DC studies raise several questions about the role of plexin-
D1 in DC-T cell biology. Does absence of plexin-D1 affect T cell memory responses? How 
do PlxnD1-/- mice respond to live viral or bacterial challenge? Are PlxnD1-/- mice protected 
or susceptible to diseases such as EAE? We would expect a role for plexin-D1 in T cell 
mediated immune responses. However, it is possible that there are other mechanisms in place 
to compensate for the absence of plexin-D1 in these cells types. Given the large number of 
plexin molecules and their abundant expression in the immune system, it is possible that 
some of these molecules have functional redundancy.  
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 Our research to date suggests that plexin-D1 expression is tightly regulated in the 
immune system. Plexin-D1 regulates migratory patterns of developing thymocytes and 
activated B cells. Future work would compare regulation of plexin-D1 expression to that of 
chemokines and their receptors. This would allow us to better understand spatiotemporal 
regulation of immune cell migration. Chemokines might be important in recruiting immune 
cells to immune organs and help direct them to specific areas such as B-cell follicles or T cell 
zones. Plexin molecules may play important roles in fine-tuning these migratory processes 
and regulating immune cell migration into microenvironments. Additionally, cytokines are 
soluble molecules with low specificity for cell-migration. Plexins and semaphorins can help 
regulate cell migration via cell-cell interactions, thus increasing the specificity of immune 
cell migration in specific zones. Due to its ability to regulate different stages of cell 
development and immune responses, specifically in the formation of GCs and the generation 
of Ab-producing cells, plexin-D1 is great candidate for future research towards vaccine 
design.  
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